Source Name	Characteristics[organism]	Characteristics[organism part]	Characteristics[age]	Characteristics[sex]	Characteristics[disease]	Characteristics[ancestry category]	Characteristics[cell type]	Characteristics[cell line]	Characteristics[enrichment process]	Characteristics[biological replicate]	Material Type	assay name	Technology Type	comment[data file]	comment[file uri]	comment[technical replicate]	comment[fraction identifier]	comment[label]	comment[cleavage agent details]	comment[instrument]	comment[modification parameters]	comment[modification parameters]	comment[modification parameters]	comment[dissociation method]	comment[collision energy]	comment[precursor mass tolerance]	comment[fragment mass tolerance]	factor value[cell line]	factor value[compound]	Factor Value[compound]
Sample 1	Homo sapiens	B lymphocyte	38Y	male	Transformed follicular lymphoma	Caucasian	B lymphocyte	SU-DHL-4	glycosylation	1	cell	run 1	proteomic profiling by mass spectrometry	UM_2009_1432a-SUDHL4.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_1432a-SUDHL4.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SU-DHL-4	None	None
Sample 1	Homo sapiens	B lymphocyte	38Y	male	Transformed follicular lymphoma	Caucasian	B lymphocyte	SU-DHL-4	glycosylation	1	cell	run 2	proteomic profiling by mass spectrometry	UM_2009_1432b-SUDHL4.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_1432b-SUDHL4.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SU-DHL-4	None	None
Sample 1	Homo sapiens	B lymphocyte	38Y	male	Transformed follicular lymphoma	Caucasian	B lymphocyte	SU-DHL-4	glycosylation	1	cell	run 3	proteomic profiling by mass spectrometry	UM_2009_1432c-SUDHL4.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_1432c-SUDHL4.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SU-DHL-4	None	None
Sample 2	Homo sapiens	thyroid	71Y	male	Classical Hodgkin lymphoma	not available	not available	KMH2	glycosylation	1	cell	run 4	proteomic profiling by mass spectrometry	UM_2009_1433a-KMH2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_1433a-KMH2.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	KMH2	None	None
Sample 2	Homo sapiens	thyroid	71Y	male	Classical Hodgkin lymphoma	not available	not available	KMH2	glycosylation	1	cell	run 5	proteomic profiling by mass spectrometry	UM_2009_1433b-KMH2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_1433b-KMH2.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	KMH2	None	None
Sample 2	Homo sapiens	thyroid	71Y	male	Classical Hodgkin lymphoma	not available	not available	KMH2	glycosylation	1	cell	run 6	proteomic profiling by mass spectrometry	UM_2009_1433c-KMH2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_1433c-KMH2.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	KMH2	None	None
Sample 3	Homo sapiens	lymphoblast	38Y	male	Transformed follicular lymphoma	Caucasian	B lymphocyte	SU-DHL-4	glycosylation	2	cell	run 7	proteomic profiling by mass spectrometry	UM_2009_1603_a-SUDHL4.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_1603_a-SUDHL4.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SU-DHL-4	None	None
Sample 3	Homo sapiens	lymphoblast	38Y	male	Transformed follicular lymphoma	Caucasian	B lymphocyte	SU-DHL-4	glycosylation	2	cell	run 8	proteomic profiling by mass spectrometry	UM_2009_1603_b-SUDHL4.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_1603_b-SUDHL4.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SU-DHL-4	None	None
Sample 3	Homo sapiens	lymphoblast	38Y	male	Transformed follicular lymphoma	Caucasian	B lymphocyte	SU-DHL-4	glycosylation	2	cell	run 9	proteomic profiling by mass spectrometry	UM_2009_1603_c-SUDHL4.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_1603_c-SUDHL4.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SU-DHL-4	None	None
Sample 4	Homo sapiens	thyroid	71Y	male	Classical Hodgkin lymphoma	not available	not available	KMH2	glycosylation	2	cell	run 10	proteomic profiling by mass spectrometry	UM_2009_1604_a-KMH2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_1604_a-KMH2.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	KMH2	None	None
Sample 4	Homo sapiens	thyroid	71Y	male	Classical Hodgkin lymphoma	not available	not available	KMH2	glycosylation	2	cell	run 11	proteomic profiling by mass spectrometry	UM_2009_1604_b-KMH2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_1604_b-KMH2.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	KMH2	None	None
Sample 4	Homo sapiens	thyroid	71Y	male	Classical Hodgkin lymphoma	not available	not available	KMH2	glycosylation	2	cell	run 12	proteomic profiling by mass spectrometry	UM_2009_1604_c-KMH2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_1604_c-KMH2.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	KMH2	None	None
Sample 5	Homo sapiens	thyroid	71Y	male	Classical Hodgkin lymphoma	not available	not available	KMH2	glycosylation	3	cell	run 13	proteomic profiling by mass spectrometry	UM_2009_1778_a-KMH2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_1778_a-KMH2.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	KMH2	None	None
Sample 5	Homo sapiens	thyroid	71Y	male	Classical Hodgkin lymphoma	not available	not available	KMH2	glycosylation	3	cell	run 14	proteomic profiling by mass spectrometry	UM_2009_1778_b-KMH2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_1778_b-KMH2.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	KMH2	None	None
Sample 5	Homo sapiens	thyroid	71Y	male	Classical Hodgkin lymphoma	not available	not available	KMH2	glycosylation	3	cell	run 15	proteomic profiling by mass spectrometry	UM_2009_1778_c-KMH2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_1778_c-KMH2.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	KMH2	None	None
Sample 6	Homo sapiens	lymphoblast	38Y	male	Transformed follicular lymphoma	Caucasian	B lymphocyte	SU-DHL-4	glycosylation	3	cell	run 16	proteomic profiling by mass spectrometry	UM_2009_a_1383-SUDHL4.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_a_1383-SUDHL4.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SU-DHL-4	None	None
Sample 6	Homo sapiens	lymphoblast	38Y	male	Transformed follicular lymphoma	Caucasian	B lymphocyte	SU-DHL-4	glycosylation	3	cell	run 17	proteomic profiling by mass spectrometry	UM_2009_A_2098_a1-SUDHL1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2098_a1-SUDHL1.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SU-DHL-4	None	None
Sample 6	Homo sapiens	lymphoblast	38Y	male	Transformed follicular lymphoma	Caucasian	B lymphocyte	SU-DHL-4	glycosylation	3	cell	run 18	proteomic profiling by mass spectrometry	UM_2009_A_2098_a2-SUDHL1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2098_a2-SUDHL1.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SU-DHL-4	None	None
Sample 7	Homo sapiens	lymph node	10Y	male	diffuse histiocytic lymphoma	Caucasian	histiocytic	SUD-HL-1	glycosylation	1	cell	run 19	proteomic profiling by mass spectrometry	UM_2009_A_2098_a3-SUDHL1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2098_a3-SUDHL1.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SUD-HL-1	None	None
Sample 7	Homo sapiens	lymph node	10Y	male	diffuse histiocytic lymphoma	Caucasian	histiocytic	SUD-HL-1	glycosylation	1	cell	run 20	proteomic profiling by mass spectrometry	UM_2009_A_2099_a1-MEDB1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2099_a1-MEDB1.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SUD-HL-1	None	None
Sample 7	Homo sapiens	lymph node	10Y	male	diffuse histiocytic lymphoma	Caucasian	histiocytic	SUD-HL-1	glycosylation	1	cell	run 21	proteomic profiling by mass spectrometry	UM_2009_A_2099_a2-MEDB1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2099_a2-MEDB1.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SUD-HL-1	None	None
Sample 8	Homo sapiens	lymphoblast	not available	not available	Primary mediastinal large B-cell lymphoma	not available	B lymphocyte	Med-B1	glycosylation	1	cell	run 22	proteomic profiling by mass spectrometry	UM_2009_A_2099_a3-MEDB1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2099_a3-MEDB1.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Med-B1	None	None
Sample 8	Homo sapiens	lymphoblast	not available	not available	Primary mediastinal large B-cell lymphoma	not available	B lymphocyte	Med-B1	glycosylation	1	cell	run 23	proteomic profiling by mass spectrometry	UM_2009_A_2100_a1-DEL.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2100_a1-DEL.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Med-B1	None	None
Sample 8	Homo sapiens	lymphoblast	not available	not available	Primary mediastinal large B-cell lymphoma	not available	B lymphocyte	Med-B1	glycosylation	1	cell	run 24	proteomic profiling by mass spectrometry	UM_2009_A_2100_a2-DEL.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2100_a2-DEL.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Med-B1	None	None
Sample 9	Homo sapiens	not available	not available	not available	Anaplastic large cell lymphoma	not available	not available	DEL	glycosylation	1	cell	run 25	proteomic profiling by mass spectrometry	UM_2009_A_2100_a3-DEL.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2100_a3-DEL.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	DEL	None	None
Sample 9	Homo sapiens	not available	not available	not available	Anaplastic large cell lymphoma	not available	not available	DEL	glycosylation	1	cell	run 26	proteomic profiling by mass spectrometry	UM_2009_A_2233_a1-DEL.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2233_a1-DEL.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	DEL	None	None
Sample 9	Homo sapiens	not available	not available	not available	Anaplastic large cell lymphoma	not available	not available	DEL	glycosylation	1	cell	run 27	proteomic profiling by mass spectrometry	UM_2009_A_2233_a2-DEL.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2233_a2-DEL.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	DEL	None	None
Sample 10	Homo sapiens	not available	not available	not available	Anaplastic large cell lymphoma	not available	not available	DEL	glycosylation	2	cell	run 28	proteomic profiling by mass spectrometry	UM_2009_A_2233_a3-DEL.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2233_a3-DEL.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	DEL	None	None
Sample 10	Homo sapiens	not available	not available	not available	Anaplastic large cell lymphoma	not available	not available	DEL	glycosylation	2	cell	run 29	proteomic profiling by mass spectrometry	UM_2009_A_2234_a1-KARPAS1106P.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2234_a1-KARPAS1106P.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	DEL	None	None
Sample 10	Homo sapiens	not available	not available	not available	Anaplastic large cell lymphoma	not available	not available	DEL	glycosylation	2	cell	run 30	proteomic profiling by mass spectrometry	UM_2009_A_2234_a2-KARPAS1106P.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2234_a2-KARPAS1106P.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	DEL	None	None
Sample 11	Homo sapiens	Blood	not available	not available	Primary mediastinal large B-cell lymphoma	not available	B cell lymphoma	Karpas 1106P	glycosylation	1	cell	run 31	proteomic profiling by mass spectrometry	UM_2009_A_2234_a3-KARPAS1106P.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2234_a3-KARPAS1106P.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Karpas 1106P	None	None
Sample 11	Homo sapiens	Blood	not available	not available	Primary mediastinal large B-cell lymphoma	not available	B cell lymphoma	Karpas 1106P	glycosylation	1	cell	run 32	proteomic profiling by mass spectrometry	UM_2009_A_2479_a1-DEL.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2479_a1-DEL.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Karpas 1106P	None	None
Sample 11	Homo sapiens	Blood	not available	not available	Primary mediastinal large B-cell lymphoma	not available	B cell lymphoma	Karpas 1106P	glycosylation	1	cell	run 33	proteomic profiling by mass spectrometry	UM_2009_A_2479_a2-DEL.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2479_a2-DEL.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Karpas 1106P	None	None
Sample 12	Homo sapiens	not available	not available	not available	Anaplastic large cell lymphoma	not available	not available	DEL	glycosylation	3	cell	run 34	proteomic profiling by mass spectrometry	UM_2009_A_2479_a3-DEL.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2479_a3-DEL.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	DEL	None	None
Sample 12	Homo sapiens	not available	not available	not available	Anaplastic large cell lymphoma	not available	not available	DEL	glycosylation	3	cell	run 35	proteomic profiling by mass spectrometry	UM_2009_A_2544_a1-SUDHL1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2544_a1-SUDHL1.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	DEL	None	None
Sample 12	Homo sapiens	not available	not available	not available	Anaplastic large cell lymphoma	not available	not available	DEL	glycosylation	3	cell	run 36	proteomic profiling by mass spectrometry	UM_2009_A_2544_a2-SUDHL1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2544_a2-SUDHL1.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	DEL	None	None
Sample 13	Homo sapiens	lymph node	10Y	male	diffuse histiocytic lymphoma	Caucasian	histiocytic	SUD-HL-1	glycosylation	2	cell	run 37	proteomic profiling by mass spectrometry	UM_2009_A_2544_a3-SUDHL1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2544_a3-SUDHL1.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SUD-HL-1	None	None
Sample 13	Homo sapiens	lymph node	10Y	male	diffuse histiocytic lymphoma	Caucasian	histiocytic	SUD-HL-1	glycosylation	2	cell	run 38	proteomic profiling by mass spectrometry	UM_2009_A_2561_a1-L428.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2561_a1-L428.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SUD-HL-1	None	None
Sample 13	Homo sapiens	lymph node	10Y	male	diffuse histiocytic lymphoma	Caucasian	histiocytic	SUD-HL-1	glycosylation	2	cell	run 39	proteomic profiling by mass spectrometry	UM_2009_A_2561_a2-L428.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2561_a2-L428.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SUD-HL-1	None	None
Sample 14	Homo sapiens	lymph node	not available	not available	Classical Hodgkin lymphoma	not available	not available	L428	glycosylation	1	cell	run 40	proteomic profiling by mass spectrometry	UM_2009_A_2561_a3-L428.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2561_a3-L428.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	L428	None	None
Sample 14	Homo sapiens	lymph node	not available	not available	Classical Hodgkin lymphoma	not available	not available	L428	glycosylation	1	cell	run 41	proteomic profiling by mass spectrometry	UM_2009_A_2562_a1-MEDB1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2562_a1-MEDB1.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	L428	None	None
Sample 14	Homo sapiens	lymph node	not available	not available	Classical Hodgkin lymphoma	not available	not available	L428	glycosylation	1	cell	run 42	proteomic profiling by mass spectrometry	UM_2009_A_2562_a2-MEDB1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2562_a2-MEDB1.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	L428	None	None
Sample 15	Homo sapiens	lymphoblast	not available	not available	Primary mediastinal large B-cell lymphoma	not available	B lymphocyte	Med-B1	glycosylation	2	cell	run 43	proteomic profiling by mass spectrometry	UM_2009_A_2562_a3-MEDB1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2562_a3-MEDB1.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Med-B1	None	None
Sample 15	Homo sapiens	lymphoblast	not available	not available	Primary mediastinal large B-cell lymphoma	not available	B lymphocyte	Med-B1	glycosylation	2	cell	run 44	proteomic profiling by mass spectrometry	UM_2009_A_2677_a1-SUDHL1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2677_a1-SUDHL1.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Med-B1	None	None
Sample 15	Homo sapiens	lymphoblast	not available	not available	Primary mediastinal large B-cell lymphoma	not available	B lymphocyte	Med-B1	glycosylation	2	cell	run 45	proteomic profiling by mass spectrometry	UM_2009_A_2677_a2-SUDHL1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2677_a2-SUDHL1.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Med-B1	None	None
Sample 16	Homo sapiens	lymph node	10Y	male	diffuse histiocytic lymphoma	Caucasian	histiocytic	SUD-HL-1	glycosylation	3	cell	run 46	proteomic profiling by mass spectrometry	UM_2009_A_2677_a3-SUDHL1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2677_a3-SUDHL1.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SUD-HL-1	None	None
Sample 16	Homo sapiens	lymph node	10Y	male	diffuse histiocytic lymphoma	Caucasian	histiocytic	SUD-HL-1	glycosylation	3	cell	run 47	proteomic profiling by mass spectrometry	UM_2009_A_2678_a1-OCILY2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2678_a1-OCILY2.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SUD-HL-1	None	None
Sample 16	Homo sapiens	lymph node	10Y	male	diffuse histiocytic lymphoma	Caucasian	histiocytic	SUD-HL-1	glycosylation	3	cell	run 48	proteomic profiling by mass spectrometry	UM_2009_A_2678_a2-OCILY2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2678_a2-OCILY2.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SUD-HL-1	None	None
Sample 17	Homo sapiens	lymph node	not available	not available	Diffuse large B-cell lymphoma	not available	not available	OCI-Ly2	glycosylation	1	cell	run 49	proteomic profiling by mass spectrometry	UM_2009_A_2678_a3-OCILY2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2678_a3-OCILY2.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	OCI-Ly2	None	None
Sample 17	Homo sapiens	lymph node	not available	not available	Diffuse large B-cell lymphoma	not available	not available	OCI-Ly2	glycosylation	1	cell	run 50	proteomic profiling by mass spectrometry	UM_2009_A_2764_a1-L428.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2764_a1-L428.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	OCI-Ly2	None	None
Sample 17	Homo sapiens	lymph node	not available	not available	Diffuse large B-cell lymphoma	not available	not available	OCI-Ly2	glycosylation	1	cell	run 51	proteomic profiling by mass spectrometry	UM_2009_A_2764_a2-L428.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2764_a2-L428.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	OCI-Ly2	None	None
Sample 18	Homo sapiens	lymph node	not available	not available	Classical Hodgkin lymphoma	not available	not available	L428	glycosylation	2	cell	run 52	proteomic profiling by mass spectrometry	UM_2009_A_2764_a3-L428.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2764_a3-L428.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	L428	None	None
Sample 18	Homo sapiens	lymph node	not available	not available	Classical Hodgkin lymphoma	not available	not available	L428	glycosylation	2	cell	run 53	proteomic profiling by mass spectrometry	UM_2009_A_2765_a1-MEDB1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2765_a1-MEDB1.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	L428	None	None
Sample 18	Homo sapiens	lymph node	not available	not available	Classical Hodgkin lymphoma	not available	not available	L428	glycosylation	2	cell	run 54	proteomic profiling by mass spectrometry	UM_2009_A_2765_a2-MEDB1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2765_a2-MEDB1.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	L428	None	None
Sample 19	Homo sapiens	B lymphocyte	not available	not available	Primary mediastinal large B-cell lymphoma	not available	B lymphocyte	Med-B1	glycosylation	3	cell	run 55	proteomic profiling by mass spectrometry	UM_2009_A_2765_a3-MEDB1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2765_a3-MEDB1.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Med-B1	None	None
Sample 19	Homo sapiens	B lymphocyte	not available	not available	Primary mediastinal large B-cell lymphoma	not available	B lymphocyte	Med-B1	glycosylation	3	cell	run 56	proteomic profiling by mass spectrometry	UM_2009_A_2823_a1-L428.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2823_a1-L428.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Med-B1	None	None
Sample 19	Homo sapiens	B lymphocyte	not available	not available	Primary mediastinal large B-cell lymphoma	not available	B lymphocyte	Med-B1	glycosylation	3	cell	run 57	proteomic profiling by mass spectrometry	UM_2009_A_2823_a2-L428.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2823_a2-L428.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Med-B1	None	None
Sample 20	Homo sapiens	lymph node	not available	not available	Classical Hodgkin lymphoma	not available	not available	L428	glycosylation	3	cell	run 58	proteomic profiling by mass spectrometry	UM_2009_A_2823_a3-L428.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2823_a3-L428.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	L428	None	None
Sample 20	Homo sapiens	lymph node	not available	not available	Classical Hodgkin lymphoma	not available	not available	L428	glycosylation	3	cell	run 59	proteomic profiling by mass spectrometry	UM_2009_A_2824_a1-KARPAS1106P.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2824_a1-KARPAS1106P.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	L428	None	None
Sample 20	Homo sapiens	lymph node	not available	not available	Classical Hodgkin lymphoma	not available	not available	L428	glycosylation	3	cell	run 60	proteomic profiling by mass spectrometry	UM_2009_A_2824_a2-KARPAS1106P.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2824_a2-KARPAS1106P.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	L428	None	None
Sample 21	Homo sapiens	Blood	not available	not available	Primary mediastinal large B-cell lymphoma	not available	B cell lymphoma	Karpas 1106P	glycosylation	2	cell	run 61	proteomic profiling by mass spectrometry	UM_2009_A_2824_a3-KARPAS1106P.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2824_a3-KARPAS1106P.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Karpas 1106P	None	None
Sample 21	Homo sapiens	Blood	not available	not available	Primary mediastinal large B-cell lymphoma	not available	B cell lymphoma	Karpas 1106P	glycosylation	2	cell	run 62	proteomic profiling by mass spectrometry	UM_2009_A_2881_a1-KARPAS1106P.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2881_a1-KARPAS1106P.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Karpas 1106P	None	None
Sample 21	Homo sapiens	Blood	not available	not available	Primary mediastinal large B-cell lymphoma	not available	B cell lymphoma	Karpas 1106P	glycosylation	2	cell	run 63	proteomic profiling by mass spectrometry	UM_2009_A_2881_a2-KARPAS1106P.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2881_a2-KARPAS1106P.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Karpas 1106P	None	None
Sample 22	Homo sapiens	Blood	not available	not available	Primary mediastinal large B-cell lymphoma	not available	B cell lymphoma	Karpas 1106P	glycosylation	3	cell	run 64	proteomic profiling by mass spectrometry	UM_2009_A_2881_a3-KARPAS1106P.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2881_a3-KARPAS1106P.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Karpas 1106P	None	None
Sample 22	Homo sapiens	Blood	not available	not available	Primary mediastinal large B-cell lymphoma	not available	B cell lymphoma	Karpas 1106P	glycosylation	3	cell	run 65	proteomic profiling by mass spectrometry	UM_2009_A_2914_a1-NCEB1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2914_a1-NCEB1.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Karpas 1106P	None	None
Sample 22	Homo sapiens	Blood	not available	not available	Primary mediastinal large B-cell lymphoma	not available	B cell lymphoma	Karpas 1106P	glycosylation	3	cell	run 66	proteomic profiling by mass spectrometry	UM_2009_A_2914_a2-NCEB1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2914_a2-NCEB1.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Karpas 1106P	None	None
Sample 23	Homo sapiens	peripheral blood	57Y	not available	lymphoma	not available	lymphoblast	NCEB-1	glycosylation	1	cell	run 67	proteomic profiling by mass spectrometry	UM_2009_A_2914_a3-NCEB1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2914_a3-NCEB1.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	NCEB-1	None	None
Sample 23	Homo sapiens	peripheral blood	57Y	not available	lymphoma	not available	lymphoblast	NCEB-1	glycosylation	1	cell	run 68	proteomic profiling by mass spectrometry	UM_2009_A_2915_a1-FL218.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2915_a1-FL218.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	NCEB-1	None	None
Sample 23	Homo sapiens	peripheral blood	57Y	not available	lymphoma	not available	lymphoblast	NCEB-1	glycosylation	1	cell	run 69	proteomic profiling by mass spectrometry	UM_2009_A_2915_a2-FL218.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2915_a2-FL218.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	NCEB-1	None	None
Sample 24	Homo sapiens	lymphoblast	not available	not available	Transformed follicular lymphoma	not available	B lymphocyte	FL-218	glycosylation	1	cell	run 70	proteomic profiling by mass spectrometry	UM_2009_A_2915_a3-FL218.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2915_a3-FL218.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	FL-218	None	None
Sample 24	Homo sapiens	lymphoblast	not available	not available	Transformed follicular lymphoma	not available	B lymphocyte	FL-218	glycosylation	1	cell	run 71	proteomic profiling by mass spectrometry	UM_2009_A_2916_a1-FL218.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2916_a1-FL218.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	FL-218	None	None
Sample 24	Homo sapiens	lymphoblast	not available	not available	Transformed follicular lymphoma	not available	B lymphocyte	FL-218	glycosylation	1	cell	run 72	proteomic profiling by mass spectrometry	UM_2009_A_2916_a2-FL218.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2916_a2-FL218.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	FL-218	None	None
Sample 25	Homo sapiens	lymphoblast	not available	not available	Transformed follicular lymphoma	not available	B lymphocyte	FL-218	glycosylation	2	cell	run 73	proteomic profiling by mass spectrometry	UM_2009_A_2916_a3-FL218.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2916_a3-FL218.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	FL-218	None	None
Sample 25	Homo sapiens	lymphoblast	not available	not available	Transformed follicular lymphoma	not available	B lymphocyte	FL-218	glycosylation	2	cell	run 74	proteomic profiling by mass spectrometry	UM_2009_A_2918_a1-OCILY2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2918_a1-OCILY2.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	FL-218	None	None
Sample 25	Homo sapiens	lymphoblast	not available	not available	Transformed follicular lymphoma	not available	B lymphocyte	FL-218	glycosylation	2	cell	run 75	proteomic profiling by mass spectrometry	UM_2009_A_2918_a2-OCILY2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2918_a2-OCILY2.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	FL-218	None	None
Sample 26	Homo sapiens	lymph node	not available	not available	Diffuse large B-cell lymphoma	not available	not available	OCI-Ly2	glycosylation	2	cell	run 76	proteomic profiling by mass spectrometry	UM_2009_A_2918_a3-OCILY2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2918_a3-OCILY2.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	OCI-Ly2	None	None
Sample 26	Homo sapiens	lymph node	not available	not available	Diffuse large B-cell lymphoma	not available	not available	OCI-Ly2	glycosylation	2	cell	run 77	proteomic profiling by mass spectrometry	UM_2009_A_2920_a1-NCEB1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2920_a1-NCEB1.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	OCI-Ly2	None	None
Sample 26	Homo sapiens	lymph node	not available	not available	Diffuse large B-cell lymphoma	not available	not available	OCI-Ly2	glycosylation	2	cell	run 78	proteomic profiling by mass spectrometry	UM_2009_A_2920_a2-NCEB1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2920_a2-NCEB1.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	OCI-Ly2	None	None
Sample 27	Homo sapiens	peripheral blood	57Y	not available	lymphoma	not available	lymphoblast	NCEB-1	glycosylation	2	cell	run 79	proteomic profiling by mass spectrometry	UM_2009_A_2920_a3-NCEB1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_2920_a3-NCEB1.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	NCEB-1	None	None
Sample 27	Homo sapiens	peripheral blood	57Y	not available	lymphoma	not available	lymphoblast	NCEB-1	glycosylation	2	cell	run 80	proteomic profiling by mass spectrometry	UM_2009_A_3210_a1-RAMOS.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_3210_a1-RAMOS.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	NCEB-1	None	None
Sample 27	Homo sapiens	peripheral blood	57Y	not available	lymphoma	not available	lymphoblast	NCEB-1	glycosylation	2	cell	run 81	proteomic profiling by mass spectrometry	UM_2009_A_3210_a2-RAMOS.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_3210_a2-RAMOS.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	NCEB-1	None	None
Sample 28	Homo sapiens	lymphoblast	3Y	male	Burkitt's lymphoma (American)	Caucasian	B lymphocyte	Ramos	glycosylation	1	cell	run 82	proteomic profiling by mass spectrometry	UM_2009_A_3210_a3-RAMOS.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_3210_a3-RAMOS.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Ramos	None	None
Sample 28	Homo sapiens	lymphoblast	3Y	male	Burkitt's lymphoma (American)	Caucasian	B lymphocyte	Ramos	glycosylation	1	cell	run 83	proteomic profiling by mass spectrometry	UM_2009_A_3240_a3-RAMOS.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_3240_a3-RAMOS.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Ramos	None	None
Sample 28	Homo sapiens	lymphoblast	3Y	male	Burkitt's lymphoma (American)	Caucasian	B lymphocyte	Ramos	glycosylation	1	cell	run 84	proteomic profiling by mass spectrometry	UM_2009_A_3240_a4-RAMOS.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_3240_a4-RAMOS.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Ramos	None	None
Sample 29	Homo sapiens	lymphoblast	3Y	male	Burkitt's lymphoma (American)	Caucasian	B lymphocyte	Ramos	glycosylation	2	cell	run 85	proteomic profiling by mass spectrometry	UM_2009_A_3240_a5-RAMOS.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_3240_a5-RAMOS.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Ramos	None	None
Sample 29	Homo sapiens	lymphoblast	3Y	male	Burkitt's lymphoma (American)	Caucasian	B lymphocyte	Ramos	glycosylation	2	cell	run 86	proteomic profiling by mass spectrometry	UM_2009_A_3241_a1-DEV.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_3241_a1-DEV.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Ramos	None	None
Sample 29	Homo sapiens	lymphoblast	3Y	male	Burkitt's lymphoma (American)	Caucasian	B lymphocyte	Ramos	glycosylation	2	cell	run 87	proteomic profiling by mass spectrometry	UM_2009_A_3241_a2-DEV.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_3241_a2-DEV.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Ramos	None	None
Sample 30	Homo sapiens	lymphoblast	not available	not available	Nodular lymphocyte predominant Hodgkin lymphoma	not available	B lymphocyte	DEV	glycosylation	1	cell	run 88	proteomic profiling by mass spectrometry	UM_2009_A_3241_a3-DEV.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_3241_a3-DEV.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	DEV	None	None
Sample 30	Homo sapiens	lymphoblast	not available	not available	Nodular lymphocyte predominant Hodgkin lymphoma	not available	B lymphocyte	DEV	glycosylation	1	cell	run 89	proteomic profiling by mass spectrometry	UM_2009_A_3242_a1-DEV.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_3242_a1-DEV.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	DEV	None	None
Sample 30	Homo sapiens	lymphoblast	not available	not available	Nodular lymphocyte predominant Hodgkin lymphoma	not available	B lymphocyte	DEV	glycosylation	1	cell	run 90	proteomic profiling by mass spectrometry	UM_2009_A_3242_a2-DEV.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_3242_a2-DEV.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	DEV	None	None
Sample 31	Homo sapiens	lymphoblast	not available	not available	Nodular lymphocyte predominant Hodgkin lymphoma	not available	B lymphocyte	DEV	glycosylation	2	cell	run 91	proteomic profiling by mass spectrometry	UM_2009_A_3242_a3-DEV.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_3242_a3-DEV.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	DEV	None	None
Sample 31	Homo sapiens	lymphoblast	not available	not available	Nodular lymphocyte predominant Hodgkin lymphoma	not available	B lymphocyte	DEV	glycosylation	2	cell	run 92	proteomic profiling by mass spectrometry	UM_2009_A_3245_a1-NCEB1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_3245_a1-NCEB1.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	DEV	None	None
Sample 31	Homo sapiens	lymphoblast	not available	not available	Nodular lymphocyte predominant Hodgkin lymphoma	not available	B lymphocyte	DEV	glycosylation	2	cell	run 93	proteomic profiling by mass spectrometry	UM_2009_A_3245_a2-NCEB1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_3245_a2-NCEB1.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	DEV	None	None
Sample 32	Homo sapiens	peripheral blood	57Y	not available	lymphoma	not available	lymphoblast	NCEB-1	glycosylation	3	cell	run 94	proteomic profiling by mass spectrometry	UM_2009_A_3245_a3-NCEB1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_3245_a3-NCEB1.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	NCEB-1	None	None
Sample 32	Homo sapiens	peripheral blood	57Y	not available	lymphoma	not available	lymphoblast	NCEB-1	glycosylation	3	cell	run 95	proteomic profiling by mass spectrometry	UM_2009_A_3385_a1-OCILY2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_3385_a1-OCILY2.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	NCEB-1	None	None
Sample 32	Homo sapiens	peripheral blood	57Y	not available	lymphoma	not available	lymphoblast	NCEB-1	glycosylation	3	cell	run 96	proteomic profiling by mass spectrometry	UM_2009_A_3385_a2-OCILY2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_3385_a2-OCILY2.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	NCEB-1	None	None
Sample 33	Homo sapiens	lymph node	not available	not available	Diffuse large B-cell lymphoma	not available	not available	OCI-Ly2	glycosylation	3	cell	run 97	proteomic profiling by mass spectrometry	UM_2009_A_3385_a3-OCILY2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_3385_a3-OCILY2.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	OCI-Ly2	None	None
Sample 33	Homo sapiens	lymph node	not available	not available	Diffuse large B-cell lymphoma	not available	not available	OCI-Ly2	glycosylation	3	cell	run 98	proteomic profiling by mass spectrometry	UM_2009_A_3447_a1-FL218.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_3447_a1-FL218.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	OCI-Ly2	None	None
Sample 33	Homo sapiens	lymph node	not available	not available	Diffuse large B-cell lymphoma	not available	not available	OCI-Ly2	glycosylation	3	cell	run 99	proteomic profiling by mass spectrometry	UM_2009_A_3447_a2-FL218.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_3447_a2-FL218.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	OCI-Ly2	None	None
Sample 34	Homo sapiens	lymphoblast	not available	not available	Transformed follicular lymphoma	not available	B lymphocyte	FL-218	glycosylation	3	cell	run 100	proteomic profiling by mass spectrometry	UM_2009_A_3447_a3-FL218.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_3447_a3-FL218.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	FL-218	None	None
Sample 34	Homo sapiens	lymphoblast	not available	not available	Transformed follicular lymphoma	not available	B lymphocyte	FL-218	glycosylation	3	cell	run 101	proteomic profiling by mass spectrometry	UM_2009_A_3494_a1-RAJI.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_3494_a1-RAJI.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	FL-218	None	None
Sample 34	Homo sapiens	lymphoblast	not available	not available	Transformed follicular lymphoma	not available	B lymphocyte	FL-218	glycosylation	3	cell	run 102	proteomic profiling by mass spectrometry	UM_2009_A_3494_a2-RAJI.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_3494_a2-RAJI.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	FL-218	None	None
Sample 35	Homo sapiens	lymphoblast	11Y	male	Burkitt's lymphoma	Black	B lymphocyte	Raji	glycosylation	1	cell	run 103	proteomic profiling by mass spectrometry	UM_2009_A_3494_a3-RAJI.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_3494_a3-RAJI.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Raji	None	None
Sample 35	Homo sapiens	lymphoblast	11Y	male	Burkitt's lymphoma	Black	B lymphocyte	Raji	glycosylation	1	cell	run 104	proteomic profiling by mass spectrometry	UM_2009_A_3495_a1-RAJI.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_3495_a1-RAJI.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Raji	None	None
Sample 35	Homo sapiens	lymphoblast	11Y	male	Burkitt's lymphoma	Black	B lymphocyte	Raji	glycosylation	1	cell	run 105	proteomic profiling by mass spectrometry	UM_2009_A_3495_a2-RAJI.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_3495_a2-RAJI.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Raji	None	None
Sample 36	Homo sapiens	lymphoblast	11Y	male	Burkitt's lymphoma	Black	B lymphocyte	Raji	glycosylation	2	cell	run 106	proteomic profiling by mass spectrometry	UM_2009_A_3495_a3-RAJI.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_A_3495_a3-RAJI.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Raji	None	None
Sample 36	Homo sapiens	lymphoblast	11Y	male	Burkitt's lymphoma	Black	B lymphocyte	Raji	glycosylation	2	cell	run 107	proteomic profiling by mass spectrometry	UM_2009_b_1383-SUDHL4.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_b_1383-SUDHL4.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Raji	None	None
Sample 36	Homo sapiens	lymphoblast	11Y	male	Burkitt's lymphoma	Black	B lymphocyte	Raji	glycosylation	2	cell	run 108	proteomic profiling by mass spectrometry	UM_2009_c_1383-SUDHL4.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2009_c_1383-SUDHL4.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Raji	None	None
Sample 37	Homo sapiens	Blood	not available	not available	Mantle cell lymphoma	not available	B lymphocyte	Granta 519	glycosylation	1	cell	run 109	proteomic profiling by mass spectrometry	UM_2010_A_0003_a1-GRANTA519.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2010_A_0003_a1-GRANTA519.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Granta 519	None	None
Sample 37	Homo sapiens	Blood	not available	not available	Mantle cell lymphoma	not available	B lymphocyte	Granta 519	glycosylation	1	cell	run 110	proteomic profiling by mass spectrometry	UM_2010_A_0003_a2-GRANTA519.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2010_A_0003_a2-GRANTA519.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Granta 519	None	None
Sample 37	Homo sapiens	Blood	not available	not available	Mantle cell lymphoma	not available	B lymphocyte	Granta 519	glycosylation	1	cell	run 111	proteomic profiling by mass spectrometry	UM_2010_A_0003_a3-GRANTA519.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_2010_A_0003_a3-GRANTA519.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Granta 519	None	None
Sample 38	Homo sapiens	lymphoblast	not available	not available	Nodular lymphocyte predominant Hodgkin lymphoma	not available	B lymphocyte	DEV	glycosylation	3	cell	run 112	proteomic profiling by mass spectrometry	UM_A_2009_3243_a1-DEV.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2009_3243_a1-DEV.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	DEV	None	None
Sample 38	Homo sapiens	lymphoblast	not available	not available	Nodular lymphocyte predominant Hodgkin lymphoma	not available	B lymphocyte	DEV	glycosylation	3	cell	run 113	proteomic profiling by mass spectrometry	UM_A_2009_3243_a2-DEV.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2009_3243_a2-DEV.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	DEV	None	None
Sample 38	Homo sapiens	lymphoblast	not available	not available	Nodular lymphocyte predominant Hodgkin lymphoma	not available	B lymphocyte	DEV	glycosylation	3	cell	run 114	proteomic profiling by mass spectrometry	UM_A_2009_3243_a3-DEV.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2009_3243_a3-DEV.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	DEV	None	None
Sample 39	Homo sapiens	lymphoblast	3Y	male	Burkitt's lymphoma (American)	Caucasian	B lymphocyte	Ramos	glycosylation	3	cell	run 115	proteomic profiling by mass spectrometry	UM_A_2009_3249_a1-RAMOS.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2009_3249_a1-RAMOS.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Ramos	None	None
Sample 39	Homo sapiens	lymphoblast	3Y	male	Burkitt's lymphoma (American)	Caucasian	B lymphocyte	Ramos	glycosylation	3	cell	run 116	proteomic profiling by mass spectrometry	UM_A_2009_3249_a2-RAMOS.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2009_3249_a2-RAMOS.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Ramos	None	None
Sample 39	Homo sapiens	lymphoblast	3Y	male	Burkitt's lymphoma (American)	Caucasian	B lymphocyte	Ramos	glycosylation	3	cell	run 117	proteomic profiling by mass spectrometry	UM_A_2009_3249_a3-RAMOS.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2009_3249_a3-RAMOS.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Ramos	None	None
Sample 40	Homo sapiens	lymphoblast	11Y	male	Burkitt's lymphoma	Black	B lymphocyte	Raji	glycosylation	3	cell	run 118	proteomic profiling by mass spectrometry	UM_A_2009_3388_a1-RAJI.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2009_3388_a1-RAJI.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Raji	None	None
Sample 40	Homo sapiens	lymphoblast	11Y	male	Burkitt's lymphoma	Black	B lymphocyte	Raji	glycosylation	3	cell	run 119	proteomic profiling by mass spectrometry	UM_A_2009_3388_a2-RAJI.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2009_3388_a2-RAJI.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Raji	None	None
Sample 40	Homo sapiens	lymphoblast	11Y	male	Burkitt's lymphoma	Black	B lymphocyte	Raji	glycosylation	3	cell	run 120	proteomic profiling by mass spectrometry	UM_A_2009_3388_a3-RAJI.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2009_3388_a3-RAJI.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Raji	None	None
Sample 41	Homo sapiens	Blood	not available	not available	Mantle cell lymphoma	not available	B lymphocyte	Granta 519	glycosylation	2	cell	run 121	proteomic profiling by mass spectrometry	UM_A_2010_0004_a1-GRANTA519.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2010_0004_a1-GRANTA519.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Granta 519	None	None
Sample 41	Homo sapiens	Blood	not available	not available	Mantle cell lymphoma	not available	B lymphocyte	Granta 519	glycosylation	2	cell	run 122	proteomic profiling by mass spectrometry	UM_A_2010_0004_a2-GRANTA519.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2010_0004_a2-GRANTA519.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Granta 519	None	None
Sample 41	Homo sapiens	Blood	not available	not available	Mantle cell lymphoma	not available	B lymphocyte	Granta 519	glycosylation	2	cell	run 123	proteomic profiling by mass spectrometry	UM_A_2010_0004_a3-GRANTA519.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2010_0004_a3-GRANTA519.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Granta 519	None	None
Sample 42	Homo sapiens	lymph node	not available	not available	Classical Hodgkin lymphoma	not available	Lymphocyte	L1236	glycosylation	1	cell	run 124	proteomic profiling by mass spectrometry	UM_A_2010_0005_a1-L1236.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2010_0005_a1-L1236.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	L1236	None	None
Sample 42	Homo sapiens	lymph node	not available	not available	Classical Hodgkin lymphoma	not available	Lymphocyte	L1236	glycosylation	1	cell	run 125	proteomic profiling by mass spectrometry	UM_A_2010_0005_a2-L1236.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2010_0005_a2-L1236.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	L1236	None	None
Sample 42	Homo sapiens	lymph node	not available	not available	Classical Hodgkin lymphoma	not available	Lymphocyte	L1236	glycosylation	1	cell	run 126	proteomic profiling by mass spectrometry	UM_A_2010_0005_a3-L1236.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2010_0005_a3-L1236.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	L1236	None	None
Sample 43	Homo sapiens	lymph node	not available	not available	Classical Hodgkin lymphoma	not available	Lymphocyte	L1236	glycosylation	2	cell	run 127	proteomic profiling by mass spectrometry	UM_A_2010_0007_a1-L1236.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2010_0007_a1-L1236.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	L1236	None	None
Sample 43	Homo sapiens	lymph node	not available	not available	Classical Hodgkin lymphoma	not available	Lymphocyte	L1236	glycosylation	2	cell	run 128	proteomic profiling by mass spectrometry	UM_A_2010_0007_a2-L1236.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2010_0007_a2-L1236.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	L1236	None	None
Sample 43	Homo sapiens	lymph node	not available	not available	Classical Hodgkin lymphoma	not available	Lymphocyte	L1236	glycosylation	2	cell	run 129	proteomic profiling by mass spectrometry	UM_A_2010_0007_a3-L1236.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2010_0007_a3-L1236.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	L1236	None	None
Sample 44	Homo sapiens	Blood	not available	not available	Mantle cell lymphoma	not available	B lymphocyte	Granta 519	glycosylation	3	cell	run 130	proteomic profiling by mass spectrometry	UM_A_2010_0012_a1-GRANTA519.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2010_0012_a1-GRANTA519.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Granta 519	None	None
Sample 44	Homo sapiens	Blood	not available	not available	Mantle cell lymphoma	not available	B lymphocyte	Granta 519	glycosylation	3	cell	run 131	proteomic profiling by mass spectrometry	UM_A_2010_0012_a2-GRANTA519.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2010_0012_a2-GRANTA519.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Granta 519	None	None
Sample 44	Homo sapiens	Blood	not available	not available	Mantle cell lymphoma	not available	B lymphocyte	Granta 519	glycosylation	3	cell	run 132	proteomic profiling by mass spectrometry	UM_A_2010_0012_a3-GRANTA519.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2010_0012_a3-GRANTA519.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Granta 519	None	None
Sample 45	Homo sapiens	lymph node	not available	not available	Classical Hodgkin lymphoma	not available	Lymphocyte	L1236	glycosylation	3	cell	run 133	proteomic profiling by mass spectrometry	UM_A_2010_0013_a1-L1236.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2010_0013_a1-L1236.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	L1236	None	None
Sample 45	Homo sapiens	lymph node	not available	not available	Classical Hodgkin lymphoma	not available	Lymphocyte	L1236	glycosylation	3	cell	run 134	proteomic profiling by mass spectrometry	UM_A_2010_0013_a2-L1236.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2010_0013_a2-L1236.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	L1236	None	None
Sample 45	Homo sapiens	lymph node	not available	not available	Classical Hodgkin lymphoma	not available	Lymphocyte	L1236	glycosylation	3	cell	run 135	proteomic profiling by mass spectrometry	UM_A_2010_0013_a3-L1236.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2010_0013_a3-L1236.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	L1236	None	None
Sample 46	Homo sapiens	lymph node	not available	not available	Transformed follicular lymphoma	not available	B lymphocyte	FL-18	glycosylation	1	cell	run 136	proteomic profiling by mass spectrometry	UM_A_2011_0276_a1-FL18.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0276_a1-FL18.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	FL-18	None	None
Sample 46	Homo sapiens	lymph node	not available	not available	Transformed follicular lymphoma	not available	B lymphocyte	FL-18	glycosylation	1	cell	run 137	proteomic profiling by mass spectrometry	UM_A_2011_0276_a2-FL18.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0276_a2-FL18.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	FL-18	None	None
Sample 46	Homo sapiens	lymph node	not available	not available	Transformed follicular lymphoma	not available	B lymphocyte	FL-18	glycosylation	1	cell	run 138	proteomic profiling by mass spectrometry	UM_A_2011_0276_a3-FL18.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0276_a3-FL18.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	FL-18	None	None
Sample 47	Homo sapiens	lymph node	not available	not available	Transformed follicular lymphoma	not available	B lymphocyte	FL-318	glycosylation	1	cell	run 139	proteomic profiling by mass spectrometry	UM_A_2011_0277_a1-FL318.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0277_a1-FL318.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	FL-318	None	None
Sample 47	Homo sapiens	lymph node	not available	not available	Transformed follicular lymphoma	not available	B lymphocyte	FL-318	glycosylation	1	cell	run 140	proteomic profiling by mass spectrometry	UM_A_2011_0277_a2-FL318.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0277_a2-FL318.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	FL-318	None	None
Sample 47	Homo sapiens	lymph node	not available	not available	Transformed follicular lymphoma	not available	B lymphocyte	FL-318	glycosylation	1	cell	run 141	proteomic profiling by mass spectrometry	UM_A_2011_0277_a3-FL318.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0277_a3-FL318.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	FL-318	None	None
Sample 48	Homo sapiens	lymph node	not available	not available	Burkitt lymphoma	not available	B lymphocyte	BJA-B	glycosylation	1	cell	run 142	proteomic profiling by mass spectrometry	UM_A_2011_0316_a1-BJAB.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0316_a1-BJAB.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	BJA-B	None	None
Sample 48	Homo sapiens	lymph node	not available	not available	Burkitt lymphoma	not available	B lymphocyte	BJA-B	glycosylation	1	cell	run 143	proteomic profiling by mass spectrometry	UM_A_2011_0316_a2-BJAB.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0316_a2-BJAB.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	BJA-B	None	None
Sample 48	Homo sapiens	lymph node	not available	not available	Burkitt lymphoma	not available	B lymphocyte	BJA-B	glycosylation	1	cell	run 144	proteomic profiling by mass spectrometry	UM_A_2011_0316_a3-BJAB.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0316_a3-BJAB.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	BJA-B	None	None
Sample 49	Homo sapiens	lymph node	not available	not available	Transformed follicular lymphoma	not available	B lymphocyte	FL-318	glycosylation	2	cell	run 145	proteomic profiling by mass spectrometry	UM_A_2011_0318_a1-FL318.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0318_a1-FL318.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	FL-318	None	None
Sample 49	Homo sapiens	lymph node	not available	not available	Transformed follicular lymphoma	not available	B lymphocyte	FL-318	glycosylation	2	cell	run 146	proteomic profiling by mass spectrometry	UM_A_2011_0318_a2-FL318.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0318_a2-FL318.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	FL-318	None	None
Sample 49	Homo sapiens	lymph node	not available	not available	Transformed follicular lymphoma	not available	B lymphocyte	FL-318	glycosylation	2	cell	run 147	proteomic profiling by mass spectrometry	UM_A_2011_0318_a3-FL318.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0318_a3-FL318.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	FL-318	None	None
Sample 50	Homo sapiens	lymph node	not available	not available	Transformed follicular lymphoma	not available	B lymphocyte	FL-18	glycosylation	2	cell	run 148	proteomic profiling by mass spectrometry	UM_A_2011_0353_a1-FL18.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0353_a1-FL18.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	FL-18	None	None
Sample 50	Homo sapiens	lymph node	not available	not available	Transformed follicular lymphoma	not available	B lymphocyte	FL-18	glycosylation	2	cell	run 149	proteomic profiling by mass spectrometry	UM_A_2011_0353_a2-FL18.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0353_a2-FL18.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	FL-18	None	None
Sample 50	Homo sapiens	lymph node	not available	not available	Transformed follicular lymphoma	not available	B lymphocyte	FL-18	glycosylation	2	cell	run 150	proteomic profiling by mass spectrometry	UM_A_2011_0353_a3-FL18.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0353_a3-FL18.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	FL-18	None	None
Sample 51	Homo sapiens	lymph node	not available	not available	Transformed follicular lymphoma	not available	B lymphocyte	FL-518	glycosylation	1	cell	run 151	proteomic profiling by mass spectrometry	UM_A_2011_0354_a1-FL518.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0354_a1-FL518.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	FL-518	None	None
Sample 51	Homo sapiens	lymph node	not available	not available	Transformed follicular lymphoma	not available	B lymphocyte	FL-518	glycosylation	1	cell	run 152	proteomic profiling by mass spectrometry	UM_A_2011_0354_a2-FL518.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0354_a2-FL518.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	FL-518	None	None
Sample 51	Homo sapiens	lymph node	not available	not available	Transformed follicular lymphoma	not available	B lymphocyte	FL-518	glycosylation	1	cell	run 153	proteomic profiling by mass spectrometry	UM_A_2011_0354_a3-FL518.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0354_a3-FL518.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	FL-518	None	None
Sample 52	Homo sapiens	lymph node	not available	not available	Transformed follicular lymphoma	not available	B lymphocyte	FL-18	glycosylation	3	cell	run 154	proteomic profiling by mass spectrometry	UM_A_2011_0509_a1-FL18.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0509_a1-FL18.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	FL-18	None	None
Sample 52	Homo sapiens	lymph node	not available	not available	Transformed follicular lymphoma	not available	B lymphocyte	FL-18	glycosylation	3	cell	run 155	proteomic profiling by mass spectrometry	UM_A_2011_0509_a2-FL18.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0509_a2-FL18.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	FL-18	None	None
Sample 52	Homo sapiens	lymph node	not available	not available	Transformed follicular lymphoma	not available	B lymphocyte	FL-18	glycosylation	3	cell	run 156	proteomic profiling by mass spectrometry	UM_A_2011_0509_a3-FL18.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0509_a3-FL18.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	FL-18	None	None
Sample 53	Homo sapiens	lymph node	not available	not available	Transformed follicular lymphoma	not available	B lymphocyte	FL-318	glycosylation	3	cell	run 157	proteomic profiling by mass spectrometry	UM_A_2011_0510_a1-FL318.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0510_a1-FL318.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	FL-318	None	None
Sample 53	Homo sapiens	lymph node	not available	not available	Transformed follicular lymphoma	not available	B lymphocyte	FL-318	glycosylation	3	cell	run 158	proteomic profiling by mass spectrometry	UM_A_2011_0510_a2-FL318.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0510_a2-FL318.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	FL-318	None	None
Sample 53	Homo sapiens	lymph node	not available	not available	Transformed follicular lymphoma	not available	B lymphocyte	FL-318	glycosylation	3	cell	run 159	proteomic profiling by mass spectrometry	UM_A_2011_0510_a3-FL318.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0510_a3-FL318.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	FL-318	None	None
Sample 54	Homo sapiens	lymph node	not available	not available	Transformed follicular lymphoma	not available	B lymphocyte	FL-518	glycosylation	2	cell	run 160	proteomic profiling by mass spectrometry	UM_A_2011_0511_a1-FL518.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0511_a1-FL518.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	FL-518	None	None
Sample 54	Homo sapiens	lymph node	not available	not available	Transformed follicular lymphoma	not available	B lymphocyte	FL-518	glycosylation	2	cell	run 161	proteomic profiling by mass spectrometry	UM_A_2011_0511_a2-FL518.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0511_a2-FL518.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	FL-518	None	None
Sample 54	Homo sapiens	lymph node	not available	not available	Transformed follicular lymphoma	not available	B lymphocyte	FL-518	glycosylation	2	cell	run 162	proteomic profiling by mass spectrometry	UM_A_2011_0511_a3-FL518.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0511_a3-FL518.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	FL-518	None	None
Sample 55	Homo sapiens	lymph node	not available	not available	Burkitt lymphoma	not available	B lymphocyte	BJA-B	glycosylation	2	cell	run 163	proteomic profiling by mass spectrometry	UM_A_2011_0513_a1-BJAB.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0513_a1-BJAB.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	BJA-B	None	None
Sample 55	Homo sapiens	lymph node	not available	not available	Burkitt lymphoma	not available	B lymphocyte	BJA-B	glycosylation	2	cell	run 164	proteomic profiling by mass spectrometry	UM_A_2011_0513_a2-BJAB.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0513_a2-BJAB.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	BJA-B	None	None
Sample 55	Homo sapiens	lymph node	not available	not available	Burkitt lymphoma	not available	B lymphocyte	BJA-B	glycosylation	2	cell	run 165	proteomic profiling by mass spectrometry	UM_A_2011_0513_a3-BJAB.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0513_a3-BJAB.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	BJA-B	None	None
Sample 56	Homo sapiens	lymph node	not available	not available	Burkitt lymphoma	not available	B lymphocyte	FL-518	glycosylation	3	cell	run 166	proteomic profiling by mass spectrometry	UM_A_2011_0714_a1-FL518.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0714_a1-FL518.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	FL-518	None	None
Sample 56	Homo sapiens	lymph node	not available	not available	Burkitt lymphoma	not available	B lymphocyte	FL-518	glycosylation	3	cell	run 167	proteomic profiling by mass spectrometry	UM_A_2011_0714_a2-FL518.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0714_a2-FL518.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	FL-518	None	None
Sample 56	Homo sapiens	lymph node	not available	not available	Burkitt lymphoma	not available	B lymphocyte	FL-518	glycosylation	3	cell	run 168	proteomic profiling by mass spectrometry	UM_A_2011_0714_a3-FL518.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0714_a3-FL518.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	FL-518	None	None
Sample 57	Homo sapiens	lymph node	44Y	male	Transformed follicular lymphoma	not available	B lymphocyte	OCI-Ly1	glycosylation	1	cell	run 169	proteomic profiling by mass spectrometry	UM_A_2011_0912_a1-OCILY1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0912_a1-OCILY1.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	OCI-Ly1	None	None
Sample 57	Homo sapiens	lymph node	44Y	male	Transformed follicular lymphoma	not available	B lymphocyte	OCI-Ly1	glycosylation	1	cell	run 170	proteomic profiling by mass spectrometry	UM_A_2011_0912_a2-OCILY1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0912_a2-OCILY1.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	OCI-Ly1	None	None
Sample 57	Homo sapiens	lymph node	44Y	male	Transformed follicular lymphoma	not available	B lymphocyte	OCI-Ly1	glycosylation	1	cell	run 171	proteomic profiling by mass spectrometry	UM_A_2011_0912_a3-OCILY1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0912_a3-OCILY1.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	OCI-Ly1	None	None
Sample 58	Homo sapiens	lymph node	57Y	male	Mantle cell lymphoma	not available	lymphoblast	Rec-1	glycosylation	1	cell	run 172	proteomic profiling by mass spectrometry	UM_A_2011_0913_a1-REC1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0913_a1-REC1.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Rec-1	None	None
Sample 58	Homo sapiens	lymph node	57Y	male	Mantle cell lymphoma	not available	lymphoblast	Rec-1	glycosylation	1	cell	run 173	proteomic profiling by mass spectrometry	UM_A_2011_0913_a2-REC1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0913_a2-REC1.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Rec-1	None	None
Sample 58	Homo sapiens	lymph node	57Y	male	Mantle cell lymphoma	not available	lymphoblast	Rec-1	glycosylation	1	cell	run 174	proteomic profiling by mass spectrometry	UM_A_2011_0913_a3-REC1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0913_a3-REC1.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Rec-1	None	None
Sample 59	Homo sapiens	lymph node	44Y	male	Transformed follicular lymphoma	not available	B lymphocyte	OCI-Ly1	glycosylation	2	cell	run 175	proteomic profiling by mass spectrometry	UM_A_2011_0932_a1-OCILY1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0932_a1-OCILY1.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	OCI-Ly1	None	None
Sample 59	Homo sapiens	lymph node	44Y	male	Transformed follicular lymphoma	not available	B lymphocyte	OCI-Ly1	glycosylation	2	cell	run 176	proteomic profiling by mass spectrometry	UM_A_2011_0932_a2-OCILY1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0932_a2-OCILY1.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	OCI-Ly1	None	None
Sample 59	Homo sapiens	lymph node	44Y	male	Transformed follicular lymphoma	not available	B lymphocyte	OCI-Ly1	glycosylation	2	cell	run 177	proteomic profiling by mass spectrometry	UM_A_2011_0932_a3-OCILY1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0932_a3-OCILY1.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	OCI-Ly1	None	None
Sample 60	Homo sapiens	lymph node	57Y	male	Mantle cell lymphoma	not available	lymphoblast	Rec-1	glycosylation	2	cell	run 178	proteomic profiling by mass spectrometry	UM_A_2011_0933_a1-REC1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0933_a1-REC1.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Rec-1	None	None
Sample 60	Homo sapiens	lymph node	57Y	male	Mantle cell lymphoma	not available	lymphoblast	Rec-1	glycosylation	2	cell	run 179	proteomic profiling by mass spectrometry	UM_A_2011_0933_a2-REC1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0933_a2-REC1.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Rec-1	None	None
Sample 60	Homo sapiens	lymph node	57Y	male	Mantle cell lymphoma	not available	lymphoblast	Rec-1	glycosylation	2	cell	run 180	proteomic profiling by mass spectrometry	UM_A_2011_0933_a3-REC1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0933_a3-REC1.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Rec-1	None	None
Sample 61	Homo sapiens	lymph node	57Y	male	Mantle cell lymphoma	not available	lymphoblast	Rec-1	glycosylation	3	cell	run 181	proteomic profiling by mass spectrometry	UM_A_2011_0935_a1-REC1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0935_a1-REC1.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Rec-1	None	None
Sample 61	Homo sapiens	lymph node	57Y	male	Mantle cell lymphoma	not available	lymphoblast	Rec-1	glycosylation	3	cell	run 182	proteomic profiling by mass spectrometry	UM_A_2011_0935_a2-REC1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0935_a2-REC1.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Rec-1	None	None
Sample 61	Homo sapiens	lymph node	57Y	male	Mantle cell lymphoma	not available	lymphoblast	Rec-1	glycosylation	3	cell	run 183	proteomic profiling by mass spectrometry	UM_A_2011_0935_a3-REC1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0935_a3-REC1.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Rec-1	None	None
Sample 62	Homo sapiens	lymph node	44Y	male	Transformed follicular lymphoma	not available	B lymphocyte	OCI-Ly1	glycosylation	3	cell	run 184	proteomic profiling by mass spectrometry	UM_A_2011_0936_a1-OCILY1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0936_a1-OCILY1.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	OCI-Ly1	None	None
Sample 62	Homo sapiens	lymph node	44Y	male	Transformed follicular lymphoma	not available	B lymphocyte	OCI-Ly1	glycosylation	3	cell	run 185	proteomic profiling by mass spectrometry	UM_A_2011_0936_a2-OCILY1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0936_a2-OCILY1.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	OCI-Ly1	None	None
Sample 62	Homo sapiens	lymph node	44Y	male	Transformed follicular lymphoma	not available	B lymphocyte	OCI-Ly1	glycosylation	3	cell	run 186	proteomic profiling by mass spectrometry	UM_A_2011_0936_a3-OCILY1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_0936_a3-OCILY1.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	OCI-Ly1	None	None
Sample 63	Homo sapiens	lymph node	not available	not available	Burkitt lymphoma	not available	B lymphocyte	BJA-B	glycosylation	3	cell	run 187	proteomic profiling by mass spectrometry	UM_A_2011_1051_a1-BJAB.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_1051_a1-BJAB.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	BJA-B	None	None
Sample 63	Homo sapiens	lymph node	not available	not available	Burkitt lymphoma	not available	B lymphocyte	BJA-B	glycosylation	3	cell	run 188	proteomic profiling by mass spectrometry	UM_A_2011_1051_a2-BJAB.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_1051_a2-BJAB.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	BJA-B	None	None
Sample 63	Homo sapiens	lymph node	not available	not available	Burkitt lymphoma	not available	B lymphocyte	BJA-B	glycosylation	3	cell	run 189	proteomic profiling by mass spectrometry	UM_A_2011_1051_a3-BJAB.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_1051_a3-BJAB.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	BJA-B	None	None
Sample 64	Homo sapiens	peripheral blood	61Y	male	cutaneous T cell lymphoma	Caucasian	T lymphocyte	HH	glycosylation	1	cell	run 190	proteomic profiling by mass spectrometry	UM_A_2011_1311_a1-HH.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_1311_a1-HH.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	HH	None	None
Sample 64	Homo sapiens	peripheral blood	61Y	male	cutaneous T cell lymphoma	Caucasian	T lymphocyte	HH	glycosylation	1	cell	run 191	proteomic profiling by mass spectrometry	UM_A_2011_1311_a2-HH.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_1311_a2-HH.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	HH	None	None
Sample 64	Homo sapiens	peripheral blood	61Y	male	cutaneous T cell lymphoma	Caucasian	T lymphocyte	HH	glycosylation	1	cell	run 192	proteomic profiling by mass spectrometry	UM_A_2011_1311_a3-HH.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_1311_a3-HH.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	HH	None	None
Sample 65	Homo sapiens	peripheral blood	61Y	male	cutaneous T cell lymphoma	Caucasian	T lymphocyte	HH	glycosylation	2	cell	run 193	proteomic profiling by mass spectrometry	UM_A_2011_1312_a1-HH.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_1312_a1-HH.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	HH	None	None
Sample 65	Homo sapiens	peripheral blood	61Y	male	cutaneous T cell lymphoma	Caucasian	T lymphocyte	HH	glycosylation	2	cell	run 194	proteomic profiling by mass spectrometry	UM_A_2011_1312_a2-HH.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_1312_a2-HH.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	HH	None	None
Sample 65	Homo sapiens	peripheral blood	61Y	male	cutaneous T cell lymphoma	Caucasian	T lymphocyte	HH	glycosylation	2	cell	run 195	proteomic profiling by mass spectrometry	UM_A_2011_1312_a3-HH.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2011_1312_a3-HH.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	HH	None	None
Sample 66	Homo sapiens	peripheral blood	61Y	male	cutaneous T cell lymphoma	Caucasian	T lymphocyte	HH	glycosylation	3	cell	run 196	proteomic profiling by mass spectrometry	UM_A_2012_0175_a1-HH.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0175_a1-HH.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	HH	None	None
Sample 66	Homo sapiens	peripheral blood	61Y	male	cutaneous T cell lymphoma	Caucasian	T lymphocyte	HH	glycosylation	3	cell	run 197	proteomic profiling by mass spectrometry	UM_A_2012_0175_a2-HH.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0175_a2-HH.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	HH	None	None
Sample 66	Homo sapiens	peripheral blood	61Y	male	cutaneous T cell lymphoma	Caucasian	T lymphocyte	HH	glycosylation	3	cell	run 198	proteomic profiling by mass spectrometry	UM_A_2012_0175_a3-HH.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0175_a3-HH.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	HH	None	None
Sample 67	Homo sapiens	T lymphocyte	53Y	male	Sezary Syndrome	Caucasian	cutaneous T lymphocyte	Hut-78	glycosylation	1	cell	run 199	proteomic profiling by mass spectrometry	UM_A_2012_0218_a1-HUT78.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0218_a1-HUT78.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Hut-78	None	None
Sample 67	Homo sapiens	T lymphocyte	53Y	male	Sezary Syndrome	Caucasian	cutaneous T lymphocyte	Hut-78	glycosylation	1	cell	run 200	proteomic profiling by mass spectrometry	UM_A_2012_0218_a2-HUT78.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0218_a2-HUT78.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Hut-78	None	None
Sample 67	Homo sapiens	T lymphocyte	53Y	male	Sezary Syndrome	Caucasian	cutaneous T lymphocyte	Hut-78	glycosylation	1	cell	run 201	proteomic profiling by mass spectrometry	UM_A_2012_0218_a3-HUT78.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0218_a3-HUT78.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Hut-78	None	None
Sample 68	Homo sapiens	T lymphocyte	53Y	male	Sezary Syndrome	Caucasian	cutaneous T lymphocyte	Hut-78	glycosylation	2	cell	run 202	proteomic profiling by mass spectrometry	UM_A_2012_0471_a1-HUT78.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0471_a1-HUT78.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Hut-78	None	None
Sample 68	Homo sapiens	T lymphocyte	53Y	male	Sezary Syndrome	Caucasian	cutaneous T lymphocyte	Hut-78	glycosylation	2	cell	run 203	proteomic profiling by mass spectrometry	UM_A_2012_0471_a2-HUT78.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0471_a2-HUT78.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Hut-78	None	None
Sample 68	Homo sapiens	T lymphocyte	53Y	male	Sezary Syndrome	Caucasian	cutaneous T lymphocyte	Hut-78	glycosylation	2	cell	run 204	proteomic profiling by mass spectrometry	UM_A_2012_0471_a3-HUT78.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0471_a3-HUT78.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Hut-78	None	None
Sample 69	Homo sapiens	Lymphoma	not available	not available	Anaplastic large cell lymphoma,	not available	T lymphocyte	Karpas 299	glycosylation	1	cell	run 205	proteomic profiling by mass spectrometry	UM_A_2012_0581_a1-KARPAS299.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0581_a1-KARPAS299.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Karpas 299	None	None
Sample 69	Homo sapiens	Lymphoma	not available	not available	Anaplastic large cell lymphoma,	not available	T lymphocyte	Karpas 299	glycosylation	1	cell	run 206	proteomic profiling by mass spectrometry	UM_A_2012_0581_a2-KARPAS299.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0581_a2-KARPAS299.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Karpas 299	None	None
Sample 69	Homo sapiens	Lymphoma	not available	not available	Anaplastic large cell lymphoma,	not available	T lymphocyte	Karpas 299	glycosylation	1	cell	run 207	proteomic profiling by mass spectrometry	UM_A_2012_0581_a3-KARPAS299.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0581_a3-KARPAS299.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Karpas 299	None	None
Sample 70	Homo sapiens	Lymphoma	not available	not available	Anaplastic large cell lymphoma,	not available	T lymphocyte	Karpas 299	glycosylation	2	cell	run 208	proteomic profiling by mass spectrometry	UM_A_2012_0582_a1-KARPAS299.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0582_a1-KARPAS299.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Karpas 299	None	None
Sample 70	Homo sapiens	Lymphoma	not available	not available	Anaplastic large cell lymphoma,	not available	T lymphocyte	Karpas 299	glycosylation	2	cell	run 209	proteomic profiling by mass spectrometry	UM_A_2012_0582_a2-KARPAS299.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0582_a2-KARPAS299.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Karpas 299	None	None
Sample 70	Homo sapiens	Lymphoma	not available	not available	Anaplastic large cell lymphoma,	not available	T lymphocyte	Karpas 299	glycosylation	2	cell	run 210	proteomic profiling by mass spectrometry	UM_A_2012_0582_a3-KARPAS299.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0582_a3-KARPAS299.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Karpas 299	None	None
Sample 71	Homo sapiens	lymph node	not available	not available	Anaplastic large cell lymphoma	not available	T lymphocyte	SR-786	glycosylation	1	cell	run 211	proteomic profiling by mass spectrometry	UM_A_2012_0675_a1-SR786.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0675_a1-SR786.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SR-786	None	None
Sample 71	Homo sapiens	lymph node	not available	not available	Anaplastic large cell lymphoma	not available	T lymphocyte	SR-786	glycosylation	1	cell	run 212	proteomic profiling by mass spectrometry	UM_A_2012_0675_a2-SR786.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0675_a2-SR786.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SR-786	None	None
Sample 71	Homo sapiens	lymph node	not available	not available	Anaplastic large cell lymphoma	not available	T lymphocyte	SR-786	glycosylation	1	cell	run 213	proteomic profiling by mass spectrometry	UM_A_2012_0675_a3-SR786.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0675_a3-SR786.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SR-786	None	None
Sample 72	Homo sapiens	lymph node	not available	not available	Anaplastic large cell lymphoma	not available	T lymphocyte	SR-786	glycosylation	2	cell	run 214	proteomic profiling by mass spectrometry	UM_A_2012_0677_a1-SR786.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0677_a1-SR786.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SR-786	None	None
Sample 72	Homo sapiens	lymph node	not available	not available	Anaplastic large cell lymphoma	not available	T lymphocyte	SR-786	glycosylation	2	cell	run 215	proteomic profiling by mass spectrometry	UM_A_2012_0677_a2-SR786.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0677_a2-SR786.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SR-786	None	None
Sample 72	Homo sapiens	lymph node	not available	not available	Anaplastic large cell lymphoma	not available	T lymphocyte	SR-786	glycosylation	2	cell	run 216	proteomic profiling by mass spectrometry	UM_A_2012_0677_a3-SR786.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0677_a3-SR786.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SR-786	None	None
Sample 73	Homo sapiens	Lymphoma	not available	not available	Anaplastic large cell lymphoma,	not available	T lymphocyte	Karpas 299	glycosylation	3	cell	run 217	proteomic profiling by mass spectrometry	UM_A_2012_0715_a1-KARPAS299.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0715_a1-KARPAS299.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Karpas 299	None	None
Sample 73	Homo sapiens	Lymphoma	not available	not available	Anaplastic large cell lymphoma,	not available	T lymphocyte	Karpas 299	glycosylation	3	cell	run 218	proteomic profiling by mass spectrometry	UM_A_2012_0715_a2-KARPAS299.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0715_a2-KARPAS299.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Karpas 299	None	None
Sample 73	Homo sapiens	Lymphoma	not available	not available	Anaplastic large cell lymphoma,	not available	T lymphocyte	Karpas 299	glycosylation	3	cell	run 219	proteomic profiling by mass spectrometry	UM_A_2012_0715_a3-KARPAS299.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0715_a3-KARPAS299.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Karpas 299	None	None
Sample 74	Homo sapiens	Lymphoma	not available	not available	Anaplastic large cell lymphoma	not available	T lymphocyte	SUP-M2	glycosylation	1	cell	run 220	proteomic profiling by mass spectrometry	UM_A_2012_0738_a1-SUPM2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0738_a1-SUPM2.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SUP-M2	None	None
Sample 74	Homo sapiens	Lymphoma	not available	not available	Anaplastic large cell lymphoma	not available	T lymphocyte	SUP-M2	glycosylation	1	cell	run 221	proteomic profiling by mass spectrometry	UM_A_2012_0738_a2-SUPM2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0738_a2-SUPM2.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SUP-M2	None	None
Sample 74	Homo sapiens	Lymphoma	not available	not available	Anaplastic large cell lymphoma	not available	T lymphocyte	SUP-M2	glycosylation	1	cell	run 222	proteomic profiling by mass spectrometry	UM_A_2012_0738_a3-SUPM2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0738_a3-SUPM2.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SUP-M2	None	None
Sample 75	Homo sapiens	Lymphoma	not available	not available	Anaplastic large cell lymphoma	not available	T lymphocyte	SUP-M2	glycosylation	2	cell	run 223	proteomic profiling by mass spectrometry	UM_A_2012_0739_a1-SUPM2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0739_a1-SUPM2.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SUP-M2	None	None
Sample 75	Homo sapiens	Lymphoma	not available	not available	Anaplastic large cell lymphoma	not available	T lymphocyte	SUP-M2	glycosylation	2	cell	run 224	proteomic profiling by mass spectrometry	UM_A_2012_0739_a2-SUPM2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0739_a2-SUPM2.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SUP-M2	None	None
Sample 75	Homo sapiens	Lymphoma	not available	not available	Anaplastic large cell lymphoma	not available	T lymphocyte	SUP-M2	glycosylation	2	cell	run 225	proteomic profiling by mass spectrometry	UM_A_2012_0739_a3-SUPM2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0739_a3-SUPM2.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SUP-M2	None	None
Sample 76	Homo sapiens	Lymphoma	not available	not available	Anaplastic large cell lymphoma	not available	T lymphocyte	SUP-M2	glycosylation	3	cell	run 226	proteomic profiling by mass spectrometry	UM_A_2012_0740_a1-SUPM2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0740_a1-SUPM2.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SUP-M2	None	None
Sample 76	Homo sapiens	Lymphoma	not available	not available	Anaplastic large cell lymphoma	not available	T lymphocyte	SUP-M2	glycosylation	3	cell	run 227	proteomic profiling by mass spectrometry	UM_A_2012_0740_a2-SUPM2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0740_a2-SUPM2.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SUP-M2	None	None
Sample 76	Homo sapiens	Lymphoma	not available	not available	Anaplastic large cell lymphoma	not available	T lymphocyte	SUP-M2	glycosylation	3	cell	run 228	proteomic profiling by mass spectrometry	UM_A_2012_0740_a3-SUPM2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0740_a3-SUPM2.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SUP-M2	None	None
Sample 77	Homo sapiens	lymphoblastic	15Y	male	Aggressive NK-cell leukemia	not available	lymphoblastic	YT	glycosylation	1	cell	run 229	proteomic profiling by mass spectrometry	UM_A_2012_0770_a1-YT.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0770_a1-YT.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	YT	None	None
Sample 77	Homo sapiens	lymphoblastic	15Y	male	Aggressive NK-cell leukemia	not available	lymphoblastic	YT	glycosylation	1	cell	run 230	proteomic profiling by mass spectrometry	UM_A_2012_0770_a2-YT.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0770_a2-YT.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	YT	None	None
Sample 77	Homo sapiens	lymphoblastic	15Y	male	Aggressive NK-cell leukemia	not available	lymphoblastic	YT	glycosylation	1	cell	run 231	proteomic profiling by mass spectrometry	UM_A_2012_0770_a3-YT.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0770_a3-YT.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	YT	None	None
Sample 78	Homo sapiens	lymphoblastic	15Y	male	Aggressive NK-cell leukemia	not available	lymphoblastic	YT	glycosylation	2	cell	run 232	proteomic profiling by mass spectrometry	UM_A_2012_0771_a1-YT.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0771_a1-YT.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	YT	None	None
Sample 78	Homo sapiens	lymphoblastic	15Y	male	Aggressive NK-cell leukemia	not available	lymphoblastic	YT	glycosylation	2	cell	run 233	proteomic profiling by mass spectrometry	UM_A_2012_0771_a2-YT.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0771_a2-YT.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	YT	None	None
Sample 78	Homo sapiens	lymphoblastic	15Y	male	Aggressive NK-cell leukemia	not available	lymphoblastic	YT	glycosylation	2	cell	run 234	proteomic profiling by mass spectrometry	UM_A_2012_0771_a3-YT.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0771_a3-YT.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	YT	None	None
Sample 79	Homo sapiens	lymphoblastic	not available	not available	Anaplastic large cell lymphoma	not available	T lymphocyte	Mac-1	glycosylation	1	cell	run 235	proteomic profiling by mass spectrometry	UM_A_2012_0772_a1-MAC1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0772_a1-MAC1.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Mac-1	None	None
Sample 79	Homo sapiens	lymphoblastic	not available	not available	Anaplastic large cell lymphoma	not available	T lymphocyte	Mac-1	glycosylation	1	cell	run 236	proteomic profiling by mass spectrometry	UM_A_2012_0772_a2-MAC1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0772_a2-MAC1.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Mac-1	None	None
Sample 79	Homo sapiens	lymphoblastic	not available	not available	Anaplastic large cell lymphoma	not available	T lymphocyte	Mac-1	glycosylation	1	cell	run 237	proteomic profiling by mass spectrometry	UM_A_2012_0772_a3-MAC1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0772_a3-MAC1.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Mac-1	None	None
Sample 80	Homo sapiens	lymph node	not available	not available	Anaplastic large cell lymphoma	not available	T lymphocyte	SR-786	glycosylation	3	cell	run 238	proteomic profiling by mass spectrometry	UM_A_2012_0816_a1-SR786.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0816_a1-SR786.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SR-786	None	None
Sample 80	Homo sapiens	lymph node	not available	not available	Anaplastic large cell lymphoma	not available	T lymphocyte	SR-786	glycosylation	3	cell	run 239	proteomic profiling by mass spectrometry	UM_A_2012_0816_a2-SR786.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0816_a2-SR786.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SR-786	None	None
Sample 80	Homo sapiens	lymph node	not available	not available	Anaplastic large cell lymphoma	not available	T lymphocyte	SR-786	glycosylation	3	cell	run 240	proteomic profiling by mass spectrometry	UM_A_2012_0816_a3-SR786.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0816_a3-SR786.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SR-786	None	None
Sample 81	Homo sapiens	lymphoblastic	not available	not available	Anaplastic large cell lymphoma	not available	T lymphocyte	Mac-1	glycosylation	2	cell	run 241	proteomic profiling by mass spectrometry	UM_A_2012_0818_a1-MAC1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0818_a1-MAC1.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Mac-1	None	None
Sample 81	Homo sapiens	lymphoblastic	not available	not available	Anaplastic large cell lymphoma	not available	T lymphocyte	Mac-1	glycosylation	2	cell	run 242	proteomic profiling by mass spectrometry	UM_A_2012_0818_a2-MAC1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0818_a2-MAC1.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Mac-1	None	None
Sample 81	Homo sapiens	lymphoblastic	not available	not available	Anaplastic large cell lymphoma	not available	T lymphocyte	Mac-1	glycosylation	2	cell	run 243	proteomic profiling by mass spectrometry	UM_A_2012_0818_a3-MAC1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0818_a3-MAC1.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Mac-1	None	None
Sample 82	Homo sapiens	lymphoblastic	not available	male	acute T cell leukemia		T lymphocyte	Jurkat	glycosylation	1	cell	run 244	proteomic profiling by mass spectrometry	UM_A_2012_0863_a1-JURKAT.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0863_a1-JURKAT.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Jurkat	None	None
Sample 82	Homo sapiens	lymphoblastic	not available	male	acute T cell leukemia		T lymphocyte	Jurkat	glycosylation	1	cell	run 245	proteomic profiling by mass spectrometry	UM_A_2012_0863_a2-JURKAT.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0863_a2-JURKAT.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Jurkat	None	None
Sample 82	Homo sapiens	lymphoblastic	not available	male	acute T cell leukemia		T lymphocyte	Jurkat	glycosylation	1	cell	run 246	proteomic profiling by mass spectrometry	UM_A_2012_0863_a3-JURKAT.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0863_a3-JURKAT.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Jurkat	None	None
Sample 83	Homo sapiens	lymphoblastic	not available	male	acute T cell leukemia		T lymphocyte	Jurkat	glycosylation	2	cell	run 247	proteomic profiling by mass spectrometry	UM_A_2012_0864_a1-JURKAT.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0864_a1-JURKAT.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Jurkat	None	None
Sample 83	Homo sapiens	lymphoblastic	not available	male	acute T cell leukemia		T lymphocyte	Jurkat	glycosylation	2	cell	run 248	proteomic profiling by mass spectrometry	UM_A_2012_0864_a2-JURKAT.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0864_a2-JURKAT.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Jurkat	None	None
Sample 83	Homo sapiens	lymphoblastic	not available	male	acute T cell leukemia		T lymphocyte	Jurkat	glycosylation	2	cell	run 249	proteomic profiling by mass spectrometry	UM_A_2012_0864_a3-JURKAT.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0864_a3-JURKAT.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Jurkat	None	None
Sample 84	Homo sapiens	lymphoblastic	not available	male	acute T cell leukemia		T lymphocyte	Jurkat	glycosylation	3	cell	run 250	proteomic profiling by mass spectrometry	UM_A_2012_0866_a1-JURKAT.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0866_a1-JURKAT.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Jurkat	None	None
Sample 84	Homo sapiens	lymphoblastic	not available	male	acute T cell leukemia		T lymphocyte	Jurkat	glycosylation	3	cell	run 251	proteomic profiling by mass spectrometry	UM_A_2012_0866_a2-JURKAT.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0866_a2-JURKAT.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Jurkat	None	None
Sample 84	Homo sapiens	lymphoblastic	not available	male	acute T cell leukemia		T lymphocyte	Jurkat	glycosylation	3	cell	run 252	proteomic profiling by mass spectrometry	UM_A_2012_0866_a3-JURKAT.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0866_a3-JURKAT.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Jurkat	None	None
Sample 85	Homo sapiens	peripheral blood	75Y	female	Mantle cell lymphoma	not applicable	not applicable	not applicable	glycosylation	1	cell	run 253	proteomic profiling by mass spectrometry	UM_A_2012_0916_a1-PATEINT_3.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0916_a1-PATEINT_3.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	not applicable	None	None
Sample 85	Homo sapiens	peripheral blood	75Y	female	Mantle cell lymphoma	not applicable	not applicable	not applicable	glycosylation	1	cell	run 254	proteomic profiling by mass spectrometry	UM_A_2012_0916_a2-PATEINT_3.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0916_a2-PATEINT_3.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	not applicable	None	None
Sample 85	Homo sapiens	peripheral blood	75Y	female	Mantle cell lymphoma	not applicable	not applicable	not applicable	glycosylation	1	cell	run 255	proteomic profiling by mass spectrometry	UM_A_2012_0916_a3-PATEINT_3.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0916_a3-PATEINT_3.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	not applicable	None	None
Sample 86	Homo sapiens	peripheral blood	79Y	female	follicular lymphoma	not applicable	not applicable	not applicable	glycosylation	1	cell	run 256	proteomic profiling by mass spectrometry	UM_A_2012_0917_a1-PATEINT_6.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0917_a1-PATEINT_6.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	not applicable	None	None
Sample 86	Homo sapiens	peripheral blood	79Y	female	follicular lymphoma	not applicable	not applicable	not applicable	glycosylation	1	cell	run 257	proteomic profiling by mass spectrometry	UM_A_2012_0917_a2-PATEINT_6.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0917_a2-PATEINT_6.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	not applicable	None	None
Sample 86	Homo sapiens	peripheral blood	79Y	female	follicular lymphoma	not applicable	not applicable	not applicable	glycosylation	1	cell	run 258	proteomic profiling by mass spectrometry	UM_A_2012_0917_a3-PATEINT_6.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0917_a3-PATEINT_6.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	not applicable	None	None
Sample 87	Homo sapiens	peripheral blood	67Y	male	Mantle cell lymphoma	not applicable	not applicable	not applicable	glycosylation	1	cell	run 259	proteomic profiling by mass spectrometry	UM_A_2012_0960_a1-PATEINT_1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0960_a1-PATEINT_1.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	not applicable	None	None
Sample 87	Homo sapiens	peripheral blood	67Y	male	Mantle cell lymphoma	not applicable	not applicable	not applicable	glycosylation	1	cell	run 260	proteomic profiling by mass spectrometry	UM_A_2012_0960_a2-PATEINT_1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0960_a2-PATEINT_1.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	not applicable	None	None
Sample 87	Homo sapiens	peripheral blood	67Y	male	Mantle cell lymphoma	not applicable	not applicable	not applicable	glycosylation	1	cell	run 261	proteomic profiling by mass spectrometry	UM_A_2012_0960_a3-PATEINT_1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0960_a3-PATEINT_1.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	not applicable	None	None
Sample 88	Homo sapiens	peripheral blood	68Y	male	Mantle cell lymphoma	not applicable	not applicable	not applicable	glycosylation	1	cell	run 262	proteomic profiling by mass spectrometry	UM_A_2012_0961_a1-PATEINT_2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0961_a1-PATEINT_2.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	not applicable	None	None
Sample 88	Homo sapiens	peripheral blood	68Y	male	Mantle cell lymphoma	not applicable	not applicable	not applicable	glycosylation	1	cell	run 263	proteomic profiling by mass spectrometry	UM_A_2012_0961_a2-PATEINT_2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0961_a2-PATEINT_2.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	not applicable	None	None
Sample 88	Homo sapiens	peripheral blood	68Y	male	Mantle cell lymphoma	not applicable	not applicable	not applicable	glycosylation	1	cell	run 264	proteomic profiling by mass spectrometry	UM_A_2012_0961_a3-PATEINT_2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0961_a3-PATEINT_2.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	not applicable	None	None
Sample 89	Homo sapiens	peripheral blood	55Y	female	Mantle cell lymphoma	not applicable	not applicable	not applicable	glycosylation	1	cell	run 265	proteomic profiling by mass spectrometry	UM_A_2012_0962_a1-PATEINT_4.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0962_a1-PATEINT_4.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	not applicable	None	None
Sample 89	Homo sapiens	peripheral blood	55Y	female	Mantle cell lymphoma	not applicable	not applicable	not applicable	glycosylation	1	cell	run 266	proteomic profiling by mass spectrometry	UM_A_2012_0962_a2-PATEINT_4.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0962_a2-PATEINT_4.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	not applicable	None	None
Sample 89	Homo sapiens	peripheral blood	55Y	female	Mantle cell lymphoma	not applicable	not applicable	not applicable	glycosylation	1	cell	run 267	proteomic profiling by mass spectrometry	UM_A_2012_0962_a3-PATEINT_4.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0962_a3-PATEINT_4.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	not applicable	None	None
Sample 90	Homo sapiens	peripheral blood	62Y	female	follicular lymphoma	not applicable	not applicable	not applicable	glycosylation	1	cell	run 268	proteomic profiling by mass spectrometry	UM_A_2012_0963_a1-PATEINT_5.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0963_a1-PATEINT_5.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	not applicable	None	None
Sample 90	Homo sapiens	peripheral blood	62Y	female	follicular lymphoma	not applicable	not applicable	not applicable	glycosylation	1	cell	run 269	proteomic profiling by mass spectrometry	UM_A_2012_0963_a2-PATEINT_5.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0963_a2-PATEINT_5.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	not applicable	None	None
Sample 90	Homo sapiens	peripheral blood	62Y	female	follicular lymphoma	not applicable	not applicable	not applicable	glycosylation	1	cell	run 270	proteomic profiling by mass spectrometry	UM_A_2012_0963_a3-PATEINT_5.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0963_a3-PATEINT_5.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	not applicable	None	None
Sample 91	Homo sapiens	peripheral blood	63Y	female	follicular lymphoma	not applicable	not applicable	not applicable	glycosylation	1	cell	run 271	proteomic profiling by mass spectrometry	UM_A_2012_0964_a1-PATEINT_7.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0964_a1-PATEINT_7.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	not applicable	None	None
Sample 91	Homo sapiens	peripheral blood	63Y	female	follicular lymphoma	not applicable	not applicable	not applicable	glycosylation	1	cell	run 272	proteomic profiling by mass spectrometry	UM_A_2012_0964_a2-PATEINT_7.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0964_a2-PATEINT_7.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	not applicable	None	None
Sample 91	Homo sapiens	peripheral blood	63Y	female	follicular lymphoma	not applicable	not applicable	not applicable	glycosylation	1	cell	run 273	proteomic profiling by mass spectrometry	UM_A_2012_0964_a3-PATEINT_7.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0964_a3-PATEINT_7.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	not applicable	None	None
Sample 92	Homo sapiens	peripheral blood	51Y	female	follicular lymphoma	not applicable	not applicable	not applicable	glycosylation	1	cell	run 274	proteomic profiling by mass spectrometry	UM_A_2012_0965_a1-PATEINT_8.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0965_a1-PATEINT_8.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	not applicable	None	None
Sample 92	Homo sapiens	peripheral blood	51Y	female	follicular lymphoma	not applicable	not applicable	not applicable	glycosylation	1	cell	run 275	proteomic profiling by mass spectrometry	UM_A_2012_0965_a2-PATEINT_8.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0965_a2-PATEINT_8.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	not applicable	None	None
Sample 92	Homo sapiens	peripheral blood	51Y	female	follicular lymphoma	not applicable	not applicable	not applicable	glycosylation	1	cell	run 276	proteomic profiling by mass spectrometry	UM_A_2012_0965_a3-PATEINT_8.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0965_a3-PATEINT_8.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	not applicable	None	None
Sample 93	Homo sapiens	lymphoblastic	not available	not available	Anaplastic large cell lymphoma	not available	T lymphocyte	Mac-2A	glycosylation	1	cell	run 277	proteomic profiling by mass spectrometry	UM_A_2012_0974_a1-MAC2A.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0974_a1-MAC2A.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Mac-2A	None	None
Sample 93	Homo sapiens	lymphoblastic	not available	not available	Anaplastic large cell lymphoma	not available	T lymphocyte	Mac-2A	glycosylation	1	cell	run 278	proteomic profiling by mass spectrometry	UM_A_2012_0974_a2-MAC2A.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0974_a2-MAC2A.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Mac-2A	None	None
Sample 93	Homo sapiens	lymphoblastic	not available	not available	Anaplastic large cell lymphoma	not available	T lymphocyte	Mac-2A	glycosylation	1	cell	run 279	proteomic profiling by mass spectrometry	UM_A_2012_0974_a3-MAC2A.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0974_a3-MAC2A.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Mac-2A	None	None
Sample 94	Homo sapiens	lymphoblastic	not available	not available	Anaplastic large cell lymphoma	not available	T lymphocyte	Mac-2A	glycosylation	2	cell	run 280	proteomic profiling by mass spectrometry	UM_A_2012_0975_a1-MAC2A.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0975_a1-MAC2A.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Mac-2A	None	None
Sample 94	Homo sapiens	lymphoblastic	not available	not available	Anaplastic large cell lymphoma	not available	T lymphocyte	Mac-2A	glycosylation	2	cell	run 281	proteomic profiling by mass spectrometry	UM_A_2012_0975_a2-MAC2A.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0975_a2-MAC2A.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Mac-2A	None	None
Sample 94	Homo sapiens	lymphoblastic	not available	not available	Anaplastic large cell lymphoma	not available	T lymphocyte	Mac-2A	glycosylation	2	cell	run 282	proteomic profiling by mass spectrometry	UM_A_2012_0975_a3-MAC2A.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0975_a3-MAC2A.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Mac-2A	None	None
Sample 95	Homo sapiens	lymphoblastic	not available	not available	Anaplastic large cell lymphoma	not available	T lymphocyte	Mac-2A	glycosylation	3	cell	run 283	proteomic profiling by mass spectrometry	UM_A_2012_0976_a1-MAC2A.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0976_a1-MAC2A.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Mac-2A	None	None
Sample 95	Homo sapiens	lymphoblastic	not available	not available	Anaplastic large cell lymphoma	not available	T lymphocyte	Mac-2A	glycosylation	3	cell	run 284	proteomic profiling by mass spectrometry	UM_A_2012_0976_a2-MAC2A.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0976_a2-MAC2A.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Mac-2A	None	None
Sample 95	Homo sapiens	lymphoblastic	not available	not available	Anaplastic large cell lymphoma	not available	T lymphocyte	Mac-2A	glycosylation	3	cell	run 285	proteomic profiling by mass spectrometry	UM_A_2012_0976_a3-MAC2A.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0976_a3-MAC2A.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Mac-2A	None	None
Sample 96	Homo sapiens	lymphoblastic	not available	not available	Anaplastic large cell lymphoma	not available	T lymphocyte	Mac-1	glycosylation	3	cell	run 286	proteomic profiling by mass spectrometry	UM_A_2012_0977_a1-MAC1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0977_a1-MAC1.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Mac-1	None	None
Sample 96	Homo sapiens	lymphoblastic	not available	not available	Anaplastic large cell lymphoma	not available	T lymphocyte	Mac-1	glycosylation	3	cell	run 287	proteomic profiling by mass spectrometry	UM_A_2012_0977_a2-MAC1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0977_a2-MAC1.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Mac-1	None	None
Sample 96	Homo sapiens	lymphoblastic	not available	not available	Anaplastic large cell lymphoma	not available	T lymphocyte	Mac-1	glycosylation	3	cell	run 288	proteomic profiling by mass spectrometry	UM_A_2012_0977_a3-MAC1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0977_a3-MAC1.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Mac-1	None	None
Sample 97	Homo sapiens	T lymphocyte	53Y	male	Sezary Syndrome	Caucasian	cutaneous T lymphocyte	Hut-78	glycosylation	3	cell	run 289	proteomic profiling by mass spectrometry	UM_A_2012_0978_a1-HUT78.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0978_a1-HUT78.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Hut-78	None	None
Sample 97	Homo sapiens	T lymphocyte	53Y	male	Sezary Syndrome	Caucasian	cutaneous T lymphocyte	Hut-78	glycosylation	3	cell	run 290	proteomic profiling by mass spectrometry	UM_A_2012_0978_a2-HUT78.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0978_a2-HUT78.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Hut-78	None	None
Sample 97	Homo sapiens	T lymphocyte	53Y	male	Sezary Syndrome	Caucasian	cutaneous T lymphocyte	Hut-78	glycosylation	3	cell	run 291	proteomic profiling by mass spectrometry	UM_A_2012_0978_a3-HUT78.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0978_a3-HUT78.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Hut-78	None	None
Sample 98	Homo sapiens	lymphoblastic	15Y	male	Aggressive NK-cell leukemia	not available	lymphoblastic	YT	glycosylation	3	cell	run 292	proteomic profiling by mass spectrometry	UM_A_2012_0979_a1-YT.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0979_a1-YT.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	YT	None	None
Sample 98	Homo sapiens	lymphoblastic	15Y	male	Aggressive NK-cell leukemia	not available	lymphoblastic	YT	glycosylation	3	cell	run 293	proteomic profiling by mass spectrometry	UM_A_2012_0979_a2-YT.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0979_a2-YT.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	YT	None	None
Sample 98	Homo sapiens	lymphoblastic	15Y	male	Aggressive NK-cell leukemia	not available	lymphoblastic	YT	glycosylation	3	cell	run 294	proteomic profiling by mass spectrometry	UM_A_2012_0979_a3-YT.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_0979_a3-YT.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	YT	None	None
Sample 99	Homo sapiens	peripheral blood	50Y	male	malignant non-Hodgkin's lymphoma	Caucasian	natural killer cell	NK-92MI	glycosylation	1	cell	run 295	proteomic profiling by mass spectrometry	UM_A_2012_1009_a1-NK92MI.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_1009_a1-NK92MI.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	NK-92MI	None	None
Sample 99	Homo sapiens	peripheral blood	50Y	male	malignant non-Hodgkin's lymphoma	Caucasian	natural killer cell	NK-92MI	glycosylation	1	cell	run 296	proteomic profiling by mass spectrometry	UM_A_2012_1009_a2-NK92MI.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_1009_a2-NK92MI.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	NK-92MI	None	None
Sample 99	Homo sapiens	peripheral blood	50Y	male	malignant non-Hodgkin's lymphoma	Caucasian	natural killer cell	NK-92MI	glycosylation	1	cell	run 297	proteomic profiling by mass spectrometry	UM_A_2012_1009_a3-NK92MI.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_1009_a3-NK92MI.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	NK-92MI	None	None
Sample 100	Homo sapiens	peripheral blood	50Y	male	malignant non-Hodgkin's lymphoma	Caucasian	natural killer cell	NK-92MI	glycosylation	2	cell	run 298	proteomic profiling by mass spectrometry	UM_A_2012_1010_a1-NK92MI.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_1010_a1-NK92MI.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	NK-92MI	None	None
Sample 100	Homo sapiens	peripheral blood	50Y	male	malignant non-Hodgkin's lymphoma	Caucasian	natural killer cell	NK-92MI	glycosylation	2	cell	run 299	proteomic profiling by mass spectrometry	UM_A_2012_1010_a2-NK92MI.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_1010_a2-NK92MI.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	NK-92MI	None	None
Sample 100	Homo sapiens	peripheral blood	50Y	male	malignant non-Hodgkin's lymphoma	Caucasian	natural killer cell	NK-92MI	glycosylation	2	cell	run 300	proteomic profiling by mass spectrometry	UM_A_2012_1010_a3-NK92MI.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_1010_a3-NK92MI.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	NK-92MI	None	None
Sample 101	Homo sapiens	peripheral blood	50Y	male	malignant non-Hodgkin's lymphoma	Caucasian	natural killer cell	NK-92MI	glycosylation	3	cell	run 301	proteomic profiling by mass spectrometry	UM_A_2012_1011_a1-NK92MI.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_1011_a1-NK92MI.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	NK-92MI	None	None
Sample 101	Homo sapiens	peripheral blood	50Y	male	malignant non-Hodgkin's lymphoma	Caucasian	natural killer cell	NK-92MI	glycosylation	3	cell	run 302	proteomic profiling by mass spectrometry	UM_A_2012_1011_a2-NK92MI.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_1011_a2-NK92MI.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	NK-92MI	None	None
Sample 101	Homo sapiens	peripheral blood	50Y	male	malignant non-Hodgkin's lymphoma	Caucasian	natural killer cell	NK-92MI	glycosylation	3	cell	run 303	proteomic profiling by mass spectrometry	UM_A_2012_1011_a3-NK92MI.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_1011_a3-NK92MI.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	NK-92MI	None	None
Sample 102	Homo sapiens	peripheral blood	50Y	male	malignant non-Hodgkin's lymphoma	Caucasian	natural killer cell	NK-92	glycosylation	1	cell	run 304	proteomic profiling by mass spectrometry	UM_A_2012_1459_a1-NK92.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_1459_a1-NK92.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	NK-92	None	None
Sample 102	Homo sapiens	peripheral blood	50Y	male	malignant non-Hodgkin's lymphoma	Caucasian	natural killer cell	NK-92	glycosylation	1	cell	run 305	proteomic profiling by mass spectrometry	UM_A_2012_1459_a2-NK92.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_1459_a2-NK92.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	NK-92	None	None
Sample 102	Homo sapiens	peripheral blood	50Y	male	malignant non-Hodgkin's lymphoma	Caucasian	natural killer cell	NK-92	glycosylation	1	cell	run 306	proteomic profiling by mass spectrometry	UM_A_2012_1459_a3-NK92.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_1459_a3-NK92.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	NK-92	None	None
Sample 103	Homo sapiens	peripheral blood	50Y	male	malignant non-Hodgkin's lymphoma	Caucasian	natural killer cell	NK-92	glycosylation	2	cell	run 307	proteomic profiling by mass spectrometry	UM_A_2012_1460_a1-NK92.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_1460_a1-NK92.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	NK-92	None	None
Sample 103	Homo sapiens	peripheral blood	50Y	male	malignant non-Hodgkin's lymphoma	Caucasian	natural killer cell	NK-92	glycosylation	2	cell	run 308	proteomic profiling by mass spectrometry	UM_A_2012_1460_a2-NK92.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_1460_a2-NK92.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	NK-92	None	None
Sample 103	Homo sapiens	peripheral blood	50Y	male	malignant non-Hodgkin's lymphoma	Caucasian	natural killer cell	NK-92	glycosylation	2	cell	run 309	proteomic profiling by mass spectrometry	UM_A_2012_1460_a3-NK92.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_1460_a3-NK92.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	NK-92	None	None
Sample 104	Homo sapiens	peripheral blood	50Y	male	malignant non-Hodgkin's lymphoma	Caucasian	natural killer cell	NK-92	glycosylation	3	cell	run 310	proteomic profiling by mass spectrometry	UM_A_2012_1461_a1-NK92.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_1461_a1-NK92.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	NK-92	None	None
Sample 104	Homo sapiens	peripheral blood	50Y	male	malignant non-Hodgkin's lymphoma	Caucasian	natural killer cell	NK-92	glycosylation	3	cell	run 311	proteomic profiling by mass spectrometry	UM_A_2012_1461_a2-NK92.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_1461_a2-NK92.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	NK-92	None	None
Sample 104	Homo sapiens	peripheral blood	50Y	male	malignant non-Hodgkin's lymphoma	Caucasian	natural killer cell	NK-92	glycosylation	3	cell	run 312	proteomic profiling by mass spectrometry	UM_A_2012_1461_a3-NK92.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2012_1461_a3-NK92.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	NK-92	None	None
Sample 105	Homo sapiens	Lymphoma	not available	not available	Anaplastic large cell lymphoma,	not available	T lymphocyte	Karpas 299	glycosylation	1	cell	run 313	proteomic profiling by mass spectrometry	UM_A_2013_0202_a1-KARPAS299_DMSO_1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0202_a1-KARPAS299_DMSO_1.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Karpas 299	DMSO	DMSO
Sample 105	Homo sapiens	Lymphoma	not available	not available	Anaplastic large cell lymphoma,	not available	T lymphocyte	Karpas 299	glycosylation	1	cell	run 314	proteomic profiling by mass spectrometry	UM_A_2013_0202_a2-KARPAS299_DMSO_1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0202_a2-KARPAS299_DMSO_1.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Karpas 299	DMSO	DMSO
Sample 105	Homo sapiens	Lymphoma	not available	not available	Anaplastic large cell lymphoma,	not available	T lymphocyte	Karpas 299	glycosylation	1	cell	run 315	proteomic profiling by mass spectrometry	UM_A_2013_0202_a3-KARPAS299_DMSO_1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0202_a3-KARPAS299_DMSO_1.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Karpas 299	DMSO	DMSO
Sample 106	Homo sapiens	Lymphoma	not available	not available	Anaplastic large cell lymphoma,	not available	T lymphocyte	Karpas 299	glycosylation	1	cell	run 316	proteomic profiling by mass spectrometry	UM_A_2013_0203_a1-KARPAS299_ALKI_1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0203_a1-KARPAS299_ALKI_1.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Karpas 299	ALK inhibitor	ALK inhibitor
Sample 106	Homo sapiens	Lymphoma	not available	not available	Anaplastic large cell lymphoma,	not available	T lymphocyte	Karpas 299	glycosylation	1	cell	run 317	proteomic profiling by mass spectrometry	UM_A_2013_0203_a2-KARPAS299_ALKI_1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0203_a2-KARPAS299_ALKI_1.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Karpas 299	ALK inhibitor	ALK inhibitor
Sample 106	Homo sapiens	Lymphoma	not available	not available	Anaplastic large cell lymphoma,	not available	T lymphocyte	Karpas 299	glycosylation	1	cell	run 318	proteomic profiling by mass spectrometry	UM_A_2013_0203_a3-KARPAS299_ALKI_1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0203_a3-KARPAS299_ALKI_1.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Karpas 299	ALK inhibitor	ALK inhibitor
Sample 107	Homo sapiens	Lymphoma	not available	not available	Anaplastic large cell lymphoma,	not available	T lymphocyte	Karpas 299	glycosylation	2	cell	run 319	proteomic profiling by mass spectrometry	UM_A_2013_0204_a1-KARPAS299_DMSO_2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0204_a1-KARPAS299_DMSO_2.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Karpas 299	DMSO	DMSO
Sample 107	Homo sapiens	Lymphoma	not available	not available	Anaplastic large cell lymphoma,	not available	T lymphocyte	Karpas 299	glycosylation	2	cell	run 320	proteomic profiling by mass spectrometry	UM_A_2013_0204_a2-KARPAS299_DMSO_2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0204_a2-KARPAS299_DMSO_2.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Karpas 299	DMSO	DMSO
Sample 107	Homo sapiens	Lymphoma	not available	not available	Anaplastic large cell lymphoma,	not available	T lymphocyte	Karpas 299	glycosylation	2	cell	run 321	proteomic profiling by mass spectrometry	UM_A_2013_0204_a3-KARPAS299_DMSO_2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0204_a3-KARPAS299_DMSO_2.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Karpas 299	DMSO	DMSO
Sample 108	Homo sapiens	Lymphoma	not available	not available	Anaplastic large cell lymphoma,	not available	T lymphocyte	Karpas 299	glycosylation	2	cell	run 322	proteomic profiling by mass spectrometry	UM_A_2013_0205_a1-KARPAS299_ALKI_2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0205_a1-KARPAS299_ALKI_2.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Karpas 299	ALK inhibitor	ALK inhibitor
Sample 108	Homo sapiens	Lymphoma	not available	not available	Anaplastic large cell lymphoma,	not available	T lymphocyte	Karpas 299	glycosylation	2	cell	run 323	proteomic profiling by mass spectrometry	UM_A_2013_0205_a2-KARPAS299_ALKI_2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0205_a2-KARPAS299_ALKI_2.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Karpas 299	ALK inhibitor	ALK inhibitor
Sample 108	Homo sapiens	Lymphoma	not available	not available	Anaplastic large cell lymphoma,	not available	T lymphocyte	Karpas 299	glycosylation	2	cell	run 324	proteomic profiling by mass spectrometry	UM_A_2013_0205_a3-KARPAS299_ALKI_2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0205_a3-KARPAS299_ALKI_2.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Karpas 299	ALK inhibitor	ALK inhibitor
Sample 109	Homo sapiens	lymph node	10Y	male	diffuse histiocytic lymphoma	Caucasian	histiocytic	SUD-HL-1	glycosylation	1	cell	run 325	proteomic profiling by mass spectrometry	UM_A_2013_0206_a1-SUDHL1_DMSO_1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0206_a1-SUDHL1_DMSO_1.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SUD-HL-1	DMSO	DMSO
Sample 109	Homo sapiens	lymph node	10Y	male	diffuse histiocytic lymphoma	Caucasian	histiocytic	SUD-HL-1	glycosylation	1	cell	run 326	proteomic profiling by mass spectrometry	UM_A_2013_0206_a2-SUDHL1_DMSO_1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0206_a2-SUDHL1_DMSO_1.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SUD-HL-1	DMSO	DMSO
Sample 109	Homo sapiens	lymph node	10Y	male	diffuse histiocytic lymphoma	Caucasian	histiocytic	SUD-HL-1	glycosylation	1	cell	run 327	proteomic profiling by mass spectrometry	UM_A_2013_0206_a3-SUDHL1_DMSO_1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0206_a3-SUDHL1_DMSO_1.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SUD-HL-1	DMSO	DMSO
Sample 110	Homo sapiens	lymph node	10Y	male	diffuse histiocytic lymphoma	Caucasian	histiocytic	SUD-HL-1	glycosylation	1	cell	run 328	proteomic profiling by mass spectrometry	UM_A_2013_0207_a1-SUDHL1_ALKI_1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0207_a1-SUDHL1_ALKI_1.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SUD-HL-1	ALK inhibitor	ALK inhibitor
Sample 110	Homo sapiens	lymph node	10Y	male	diffuse histiocytic lymphoma	Caucasian	histiocytic	SUD-HL-1	glycosylation	1	cell	run 329	proteomic profiling by mass spectrometry	UM_A_2013_0207_a2-SUDHL1_ALKI_1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0207_a2-SUDHL1_ALKI_1.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SUD-HL-1	ALK inhibitor	ALK inhibitor
Sample 110	Homo sapiens	lymph node	10Y	male	diffuse histiocytic lymphoma	Caucasian	histiocytic	SUD-HL-1	glycosylation	1	cell	run 330	proteomic profiling by mass spectrometry	UM_A_2013_0207_a3-SUDHL1_ALKI_1.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0207_a3-SUDHL1_ALKI_1.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SUD-HL-1	ALK inhibitor	ALK inhibitor
Sample 111	Homo sapiens	peripheral blood	61Y	male	plasmacytoma	not available	B lymphocyte	RPMI 8226	glycosylation	1	cell	run 331	proteomic profiling by mass spectrometry	UM_A_2013_0230_a1-RPMI8226.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0230_a1-RPMI8226.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	RPMI 8226	None	None
Sample 111	Homo sapiens	peripheral blood	61Y	male	plasmacytoma	not available	B lymphocyte	RPMI 8226	glycosylation	1	cell	run 332	proteomic profiling by mass spectrometry	UM_A_2013_0230_a2-RPMI8226.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0230_a2-RPMI8226.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	RPMI 8226	None	None
Sample 111	Homo sapiens	peripheral blood	61Y	male	plasmacytoma	not available	B lymphocyte	RPMI 8226	glycosylation	1	cell	run 333	proteomic profiling by mass spectrometry	UM_A_2013_0230_a3-RPMI8226.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0230_a3-RPMI8226.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	RPMI 8226	None	None
Sample 112	Homo sapiens	peripheral blood	not available	female	Multiple Myeloma	not available	B lymphocyte	KMS-11	glycosylation	1	cell	run 334	proteomic profiling by mass spectrometry	UM_A_2013_0231_a1-KMS11.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0231_a1-KMS11.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	KMS-11	None	None
Sample 112	Homo sapiens	peripheral blood	not available	female	Multiple Myeloma	not available	B lymphocyte	KMS-11	glycosylation	1	cell	run 335	proteomic profiling by mass spectrometry	UM_A_2013_0231_a2-KMS11.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0231_a2-KMS11.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	KMS-11	None	None
Sample 112	Homo sapiens	peripheral blood	not available	female	Multiple Myeloma	not available	B lymphocyte	KMS-11	glycosylation	1	cell	run 336	proteomic profiling by mass spectrometry	UM_A_2013_0231_a3-KMS11.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0231_a3-KMS11.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	KMS-11	None	None
Sample 113	Homo sapiens	Lymphoma	not available	not available	Anaplastic large cell lymphoma,	not available	T lymphocyte	Karpas 299	glycosylation	3	cell	run 337	proteomic profiling by mass spectrometry	UM_A_2013_0232_a1-KARPAS299_DMSO_3.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0232_a1-KARPAS299_DMSO_3.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Karpas 299	DMSO	DMSO
Sample 113	Homo sapiens	Lymphoma	not available	not available	Anaplastic large cell lymphoma,	not available	T lymphocyte	Karpas 299	glycosylation	3	cell	run 338	proteomic profiling by mass spectrometry	UM_A_2013_0232_a2-KARPAS299_DMSO_3.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0232_a2-KARPAS299_DMSO_3.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Karpas 299	DMSO	DMSO
Sample 113	Homo sapiens	Lymphoma	not available	not available	Anaplastic large cell lymphoma,	not available	T lymphocyte	Karpas 299	glycosylation	3	cell	run 339	proteomic profiling by mass spectrometry	UM_A_2013_0232_a3-KARPAS299_DMSO_3.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0232_a3-KARPAS299_DMSO_3.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Karpas 299	DMSO	DMSO
Sample 114	Homo sapiens	Lymphoma	not available	not available	Anaplastic large cell lymphoma,	not available	T lymphocyte	Karpas 299	glycosylation	3	cell	run 340	proteomic profiling by mass spectrometry	UM_A_2013_0233_a1-KARPAS299_ALKI_3.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0233_a1-KARPAS299_ALKI_3.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Karpas 299	ALK inhibitor	ALK inhibitor
Sample 114	Homo sapiens	Lymphoma	not available	not available	Anaplastic large cell lymphoma,	not available	T lymphocyte	Karpas 299	glycosylation	3	cell	run 341	proteomic profiling by mass spectrometry	UM_A_2013_0233_a2-KARPAS299_ALKI_3.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0233_a2-KARPAS299_ALKI_3.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Karpas 299	ALK inhibitor	ALK inhibitor
Sample 114	Homo sapiens	Lymphoma	not available	not available	Anaplastic large cell lymphoma,	not available	T lymphocyte	Karpas 299	glycosylation	3	cell	run 342	proteomic profiling by mass spectrometry	UM_A_2013_0233_a3-KARPAS299_ALKI_3.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0233_a3-KARPAS299_ALKI_3.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	Karpas 299	ALK inhibitor	ALK inhibitor
Sample 115	Homo sapiens	lymph node	10Y	male	diffuse histiocytic lymphoma	Caucasian	histiocytic	SUD-HL-1	glycosylation	2	cell	run 343	proteomic profiling by mass spectrometry	UM_A_2013_0234_a1-SUDHL1_DMSO_2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0234_a1-SUDHL1_DMSO_2.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SUD-HL-1	DMSO	DMSO
Sample 115	Homo sapiens	lymph node	10Y	male	diffuse histiocytic lymphoma	Caucasian	histiocytic	SUD-HL-1	glycosylation	2	cell	run 344	proteomic profiling by mass spectrometry	UM_A_2013_0234_a2-SUDHL1_DMSO_2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0234_a2-SUDHL1_DMSO_2.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SUD-HL-1	DMSO	DMSO
Sample 115	Homo sapiens	lymph node	10Y	male	diffuse histiocytic lymphoma	Caucasian	histiocytic	SUD-HL-1	glycosylation	2	cell	run 345	proteomic profiling by mass spectrometry	UM_A_2013_0234_a3-SUDHL1_DMSO_2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0234_a3-SUDHL1_DMSO_2.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SUD-HL-1	DMSO	DMSO
Sample 116	Homo sapiens	lymph node	10Y	male	diffuse histiocytic lymphoma	Caucasian	histiocytic	SUD-HL-1	glycosylation	2	cell	run 346	proteomic profiling by mass spectrometry	UM_A_2013_0235_a1-SUDHL1_ALKI_2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0235_a1-SUDHL1_ALKI_2.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SUD-HL-1	ALK inhibitor	ALK inhibitor
Sample 116	Homo sapiens	lymph node	10Y	male	diffuse histiocytic lymphoma	Caucasian	histiocytic	SUD-HL-1	glycosylation	2	cell	run 347	proteomic profiling by mass spectrometry	UM_A_2013_0235_a2-SUDHL1_ALKI_2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0235_a2-SUDHL1_ALKI_2.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SUD-HL-1	ALK inhibitor	ALK inhibitor
Sample 116	Homo sapiens	lymph node	10Y	male	diffuse histiocytic lymphoma	Caucasian	histiocytic	SUD-HL-1	glycosylation	2	cell	run 348	proteomic profiling by mass spectrometry	UM_A_2013_0235_a3-SUDHL1_ALKI_2.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0235_a3-SUDHL1_ALKI_2.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SUD-HL-1	ALK inhibitor	ALK inhibitor
Sample 117	Homo sapiens	lymph node	10Y	male	diffuse histiocytic lymphoma	Caucasian	histiocytic	SUD-HL-1	glycosylation	3	cell	run 349	proteomic profiling by mass spectrometry	UM_A_2013_0236_a1-SUDHL1_DMSO_3.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0236_a1-SUDHL1_DMSO_3.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SUD-HL-1	DMSO	DMSO
Sample 117	Homo sapiens	lymph node	10Y	male	diffuse histiocytic lymphoma	Caucasian	histiocytic	SUD-HL-1	glycosylation	3	cell	run 350	proteomic profiling by mass spectrometry	UM_A_2013_0236_a2-SUDHL1_DMSO_3.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0236_a2-SUDHL1_DMSO_3.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SUD-HL-1	DMSO	DMSO
Sample 117	Homo sapiens	lymph node	10Y	male	diffuse histiocytic lymphoma	Caucasian	histiocytic	SUD-HL-1	glycosylation	3	cell	run 351	proteomic profiling by mass spectrometry	UM_A_2013_0236_a3-SUDHL1_DMSO_3.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0236_a3-SUDHL1_DMSO_3.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SUD-HL-1	DMSO	DMSO
Sample 118	Homo sapiens	lymph node	10Y	male	diffuse histiocytic lymphoma	Caucasian	histiocytic	SUD-HL-1	glycosylation	3	cell	run 352	proteomic profiling by mass spectrometry	UM_A_2013_0237_a1-SUDHL1_ALKI_3.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0237_a1-SUDHL1_ALKI_3.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SUD-HL-1	ALK inhibitor	ALK inhibitor
Sample 118	Homo sapiens	lymph node	10Y	male	diffuse histiocytic lymphoma	Caucasian	histiocytic	SUD-HL-1	glycosylation	3	cell	run 353	proteomic profiling by mass spectrometry	UM_A_2013_0237_a2-SUDHL1_ALKI_3.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0237_a2-SUDHL1_ALKI_3.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SUD-HL-1	ALK inhibitor	ALK inhibitor
Sample 118	Homo sapiens	lymph node	10Y	male	diffuse histiocytic lymphoma	Caucasian	histiocytic	SUD-HL-1	glycosylation	3	cell	run 354	proteomic profiling by mass spectrometry	UM_A_2013_0237_a3-SUDHL1_ALKI_3.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0237_a3-SUDHL1_ALKI_3.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	SUD-HL-1	ALK inhibitor	ALK inhibitor
Sample 119	Homo sapiens	peripheral blood	not available	female	Multiple Myeloma	not available	B lymphocyte	KMS-11	glycosylation	2	cell	run 355	proteomic profiling by mass spectrometry	UM_A_2013_0246_a1-KMS11.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0246_a1-KMS11.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	KMS-11	None	None
Sample 119	Homo sapiens	peripheral blood	not available	female	Multiple Myeloma	not available	B lymphocyte	KMS-11	glycosylation	2	cell	run 356	proteomic profiling by mass spectrometry	UM_A_2013_0246_a2-KMS11.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0246_a2-KMS11.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	KMS-11	None	None
Sample 119	Homo sapiens	peripheral blood	not available	female	Multiple Myeloma	not available	B lymphocyte	KMS-11	glycosylation	2	cell	run 357	proteomic profiling by mass spectrometry	UM_A_2013_0246_a3-KMS11.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0246_a3-KMS11.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	KMS-11	None	None
Sample 120	Homo sapiens	peripheral blood	61Y	male	plasmacytoma	not available	B lymphocyte	RPMI 8226	glycosylation	2	cell	run 358	proteomic profiling by mass spectrometry	UM_A_2013_0247_a1-RPMI8226.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0247_a1-RPMI8226.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	RPMI 8226	None	None
Sample 120	Homo sapiens	peripheral blood	61Y	male	plasmacytoma	not available	B lymphocyte	RPMI 8226	glycosylation	2	cell	run 359	proteomic profiling by mass spectrometry	UM_A_2013_0247_a2-RPMI8226.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0247_a2-RPMI8226.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	RPMI 8226	None	None
Sample 120	Homo sapiens	peripheral blood	61Y	male	plasmacytoma	not available	B lymphocyte	RPMI 8226	glycosylation	2	cell	run 360	proteomic profiling by mass spectrometry	UM_A_2013_0247_a3-RPMI8226.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0247_a3-RPMI8226.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	RPMI 8226	None	None
Sample 121	Homo sapiens	peripheral blood	not available	female	Multiple Myeloma	not available	B lymphocyte	KMS-11	glycosylation	3	cell	run 361	proteomic profiling by mass spectrometry	UM_A_2013_0250_a1-KMS11.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0250_a1-KMS11.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	KMS-11	None	None
Sample 121	Homo sapiens	peripheral blood	not available	female	Multiple Myeloma	not available	B lymphocyte	KMS-11	glycosylation	3	cell	run 362	proteomic profiling by mass spectrometry	UM_A_2013_0250_a2-KMS11.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0250_a2-KMS11.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	KMS-11	None	None
Sample 121	Homo sapiens	peripheral blood	not available	female	Multiple Myeloma	not available	B lymphocyte	KMS-11	glycosylation	3	cell	run 363	proteomic profiling by mass spectrometry	UM_A_2013_0250_a3-KMS11.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0250_a3-KMS11.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	KMS-11	None	None
Sample 122	Homo sapiens	peripheral blood	61Y	male	plasmacytoma	not available	B lymphocyte	RPMI 8226	glycosylation	3	cell	run 364	proteomic profiling by mass spectrometry	UM_A_2013_0252_a1-RPMI8226.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0252_a1-RPMI8226.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	RPMI 8226	None	None
Sample 122	Homo sapiens	peripheral blood	61Y	male	plasmacytoma	not available	B lymphocyte	RPMI 8226	glycosylation	3	cell	run 365	proteomic profiling by mass spectrometry	UM_A_2013_0252_a2-RPMI8226.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0252_a2-RPMI8226.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	RPMI 8226	None	None
Sample 122	Homo sapiens	peripheral blood	61Y	male	plasmacytoma	not available	B lymphocyte	RPMI 8226	glycosylation	3	cell	run 366	proteomic profiling by mass spectrometry	UM_A_2013_0252_a3-RPMI8226.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0252_a3-RPMI8226.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	RPMI 8226	None	None
Sample 123	Homo sapiens	peripheral blood	64Y	female	Multiple Myeloma	not available	B lymphocyte	KMS-12	glycosylation	1	cell	run 367	proteomic profiling by mass spectrometry	UM_A_2013_0255_a1-KMS12.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0255_a1-KMS12.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	KMS-12	None	None
Sample 123	Homo sapiens	peripheral blood	64Y	female	Multiple Myeloma	not available	B lymphocyte	KMS-12	glycosylation	1	cell	run 368	proteomic profiling by mass spectrometry	UM_A_2013_0255_a2-KMS12.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0255_a2-KMS12.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	KMS-12	None	None
Sample 123	Homo sapiens	peripheral blood	64Y	female	Multiple Myeloma	not available	B lymphocyte	KMS-12	glycosylation	1	cell	run 369	proteomic profiling by mass spectrometry	UM_A_2013_0255_a3-KMS12.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0255_a3-KMS12.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	KMS-12	None	None
Sample 124	Homo sapiens	peripheral blood	64Y	female	Multiple Myeloma	not available	B lymphocyte	KMS-12	glycosylation	2	cell	run 370	proteomic profiling by mass spectrometry	UM_A_2013_0787_a1-KMS12.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0787_a1-KMS12.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	KMS-12	None	None
Sample 124	Homo sapiens	peripheral blood	64Y	female	Multiple Myeloma	not available	B lymphocyte	KMS-12	glycosylation	2	cell	run 371	proteomic profiling by mass spectrometry	UM_A_2013_0787_a2-KMS12.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0787_a2-KMS12.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	KMS-12	None	None
Sample 124	Homo sapiens	peripheral blood	64Y	female	Multiple Myeloma	not available	B lymphocyte	KMS-12	glycosylation	2	cell	run 372	proteomic profiling by mass spectrometry	UM_A_2013_0787_a3-KMS12.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0787_a3-KMS12.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	KMS-12	None	None
Sample 125	Homo sapiens	peripheral blood	53Y	male	plasmacytoma	not available	B lymphocyte	U266	glycosylation	1	cell	run 373	proteomic profiling by mass spectrometry	UM_A_2013_0788_a1-U266.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0788_a1-U266.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	U266	None	None
Sample 125	Homo sapiens	peripheral blood	53Y	male	plasmacytoma	not available	B lymphocyte	U266	glycosylation	1	cell	run 374	proteomic profiling by mass spectrometry	UM_A_2013_0788_a2-U266.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0788_a2-U266.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	U266	None	None
Sample 125	Homo sapiens	peripheral blood	53Y	male	plasmacytoma	not available	B lymphocyte	U266	glycosylation	1	cell	run 375	proteomic profiling by mass spectrometry	UM_A_2013_0788_a3-U266.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0788_a3-U266.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	U266	None	None
Sample 126	Homo sapiens	peripheral blood	64Y	female	Multiple Myeloma	not available	B lymphocyte	KMS-12	glycosylation	3	cell	run 376	proteomic profiling by mass spectrometry	UM_A_2013_0978_a1-KMS12.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0978_a1-KMS12.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	KMS-12	None	None
Sample 126	Homo sapiens	peripheral blood	64Y	female	Multiple Myeloma	not available	B lymphocyte	KMS-12	glycosylation	3	cell	run 377	proteomic profiling by mass spectrometry	UM_A_2013_0978_a2-KMS12.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0978_a2-KMS12.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	KMS-12	None	None
Sample 126	Homo sapiens	peripheral blood	64Y	female	Multiple Myeloma	not available	B lymphocyte	KMS-12	glycosylation	3	cell	run 378	proteomic profiling by mass spectrometry	UM_A_2013_0978_a3-KMS12.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0978_a3-KMS12.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	KMS-12	None	None
Sample 127	Homo sapiens	peripheral blood	53Y	male	plasmacytoma	not available	B lymphocyte	U266	glycosylation	2	cell	run 379	proteomic profiling by mass spectrometry	UM_A_2013_0979_a1-U266.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0979_a1-U266.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	U266	None	None
Sample 127	Homo sapiens	peripheral blood	53Y	male	plasmacytoma	not available	B lymphocyte	U266	glycosylation	2	cell	run 380	proteomic profiling by mass spectrometry	UM_A_2013_0979_a2-U266.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0979_a2-U266.mzXML	2	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	U266	None	None
Sample 127	Homo sapiens	peripheral blood	53Y	male	plasmacytoma	not available	B lymphocyte	U266	glycosylation	2	cell	run 381	proteomic profiling by mass spectrometry	UM_A_2013_0979_a3-U266.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0979_a3-U266.mzXML	3	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	U266	None	None
Sample 128	Homo sapiens	peripheral blood	53Y	male	plasmacytoma	not available	B lymphocyte	U266	glycosylation	3	cell	run 382	proteomic profiling by mass spectrometry	UM_A_2013_0980_a1-U266.mzXML	ftp://ftp.pride.ebi.ac.uk/pride/data/archive/2017/06/PXD003469/UM_A_2013_0980_a1-U266.mzXML	1	1	AC=MS:1002038;NT=label free sample	NT=Trypsin; AC=MS:1001251	NT=LTQ Orbitrap XL;AC=MS:1000556	NT=Oxidation;MT=variable;TA=M;AC=UNIMOD:35	NT=Carbamidomethyl;TA=C;MT=variable;AC=UNIMOD:4	NT=Asn->Asp;AC=UNIMOD:621;MT=variable;TA=N	NT=collision-induced dissociation;AC=MS:1000133	35% NCE	50 ppm	0.8 Da	U266	None	None
